OSA's Digital Library

Virtual Journal for Biomedical Optics

Virtual Journal for Biomedical Optics

| EXPLORING THE INTERFACE OF LIGHT AND BIOMEDICINE

  • Editor: Gregory W. Faris
  • Vol. 4, Iss. 5 — May. 5, 2009
« Show journal navigation

Transcranial Optical Monitoring of Cerebrovascular Hemodynamics in Acute Stroke Patients

Turgut Durduran, Chao Zhou, Brian L Edlow, Guoqiang Yu, Regine Choe, Meeri N Kim, Brett L Cucchiara, Mary E Putt, Qaisar Shah, Scott E Kasner, Joel H Greenberg, Arjun G Yodh, and John A Detre  »View Author Affiliations


Optics Express, Vol. 17, Issue 5, pp. 3884-3902 (2009)
http://dx.doi.org/10.1364/OE.17.003884


View Full Text Article

Acrobat PDF (353 KB)





Browse Journals / Lookup Meetings

Browse by Journal and Year


   


Lookup Conference Papers

Close Browse Journals / Lookup Meetings

Article Tools

Share
Citations

Abstract

“Diffuse correlation spectroscopy” (DCS) is a technology for non-invasive transcranial measurement of cerebral blood flow (CBF) that can be hybridized with “near-infrared spectroscopy” (NIRS). Taken together these methods hold potential for monitoring hemodynamics in stroke patients. We explore the utility of DCS and NIRS to measure effects of head-of-bed (HOB) positioning at 30°, 15°, 0°, -5° and 0° angles in patients with acute ischemic stroke affecting frontal cortex and in controls. HOB positioning significantly altered CBF, oxy-hemoglobin (HbO2) and total-hemoglobin (THC) concentrations. Moreover, the presence of an ipsilateral infarct was a significant effect for all parameters. Results are consistent with the notion of impaired CBF autoregulation in the infarcted hemisphere.

© 2009 Optical Society of America

1. Introduction

The goal of most medical interventions in acute ischemic stroke care is to maximize blood perfusion in the affected region and surrounding ischemic penumbra by increasing local and/or global cerebral blood flow (CBF). Intervention strategies to increase CBF are based on the premise that normal autoregulation of CBF is disrupted and perfusion of the infarcted and penumbral regions are dependent on perfusion pressure [4

4. L. B. Goldstein, “Should antihypertensive therapies be given to patients with acute ischemic stroke?” Drug Saf 22(1), 13–18 (2000). [CrossRef] [PubMed]

, 5

5. S. L. Dawson, R. B. Panerai, and J. F. Potter, “Serial changes in static and dynamic cerebral autoregulation after acute ischaemic stroke,” Cerebrovasc Dis 16(1), 69–75 (2003). [CrossRef] [PubMed]

]. These interventions include keeping the patient flat, intravenous hydration, withholding anti-hypertensive therapy, and hypertensive therapy with pressor drugs. In practice, however, brain perfusion is rarely measured and a measurement of local microvascular CBF is almost entirely inaccessible. Furthermore, neurological symptoms may not occur until CBF drops to 40% of normal, and prolonged periods of cerebral ischemia increase the likelihood that neurological symptoms will become irreversible as CBF further drops to 20% of normal [6

6. K. A. Hossmann, “Viability thresholds and the penumbra of focal ischemia,” Ann Neurol 36(4), 557–565 (1994). [CrossRef] [PubMed]

, 7

7. J. Astrup, B. K. Siesjo, and L. Symon, “Thresholds in cerebral ischemia - the ischemic penumbra,” Stroke 12(6), 723–725 (1981). [CrossRef] [PubMed]

]. The ability to measure CBF at the bedside would provide new opportunities for study of cerebrovascular autoregulation, permitting hemodynamic interventions to be optimized, and potentially administered before the onset of neurological symptoms. Furthermore, because of the high prevalence of stroke and the enormous cost of its management, even strategies with modest benefits are worth pursuing.

To date, imaging modalities such as oxygen-15 positron emission tomography (15O-PET), single-photon emission computed tomography (SPECT), dynamic susceptibility contrast or arterial spin labeled bolus tracking perfusion MRI (ASL-MRI), and Xenon enhanced computed tomography (Xenon-CT) have been used to measure CBF in stroke patients [8–12

8. M. Wintermark, M. Sesay, E. Barbier, K. Borbely, W. P. Dillon, J. D. Eastwood, T. C. Glenn, C. B. Grandin, S. Pedraza, J. F. Soustiel, T. Nariai, G. Zaharchuk, J. M. Caille, V. Dousset, and H. Yonas, “Comparative overview of brain perfusion imaging techniques,” Stroke 36(9), 83–99 (2005). [CrossRef]

]. However, because they are costly and are not portable, these methods tend to be used once, if at all, during the course of a patient’s hospitalization. Furthermore, CBF can only be measured while the patient is supine for MRI, PET and CT techniques.

The primary clinical modality for serial monitoring of CBF at the bedside is the Transcranial Doppler (TCD) ultrasonography [13

13. C. C. Bishop, S. Powell, D. Rutt, and N. L. Browse, “Transcranial Doppler measurement of middle cerebral artery blood flow velocity: a validation study,” Stroke 17, 913–915 (1986). [CrossRef] [PubMed]

] technique which measures flow velocities in the major arteries. However, only the proximal portions of the intracranial arteries can be insonated and TCD provides no information about microvasculature perfusion through collateral vessels. Furthermore, since velocity changes predict CBF variation only if vessel diameters do not change, TCD has limited utility in stroke evaluation [14

14. R. R. Pindzola, J. R. Balzer, E. M. Nemoto, S. Goldstein, and H. Yonas, “Cerebrovascular reserve in patients with carotid occlusive disease assessed by stable xenon-enhanced ct cerebral blood flow and transcranial Doppler,” Stroke 32(8), 1811–1817 (2001). [CrossRef] [PubMed]

], with the best success in patients with proximal arterial occlusions [15

15. A. V. Alexandrov, A. M. Demchuk, T. H. Wein, and J. C. Grotta, “Yield of transcranial Doppler in acute cerebral ischemia,” Stroke 30(8), 1604–1609 (1999). [CrossRef] [PubMed]

]. Nevertheless, TCD has been used to monitor the effects of head-of-bed (HOB) positioning on middle cerebral artery (MCA) velocity in patients with large hemispheric strokes [16

16. S. Schwarz, D. Georgiadis, A. Aschoff, and S. Schwab, “Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke,” Stroke 33(2), 497–501 (2002). [CrossRef] [PubMed]

], finding a decrease with elevation of HOB, but only patients with partial recanalization of the MCA could be studied.

The present study explores the potential of diffuse optics for CBF monitoring at the bedside. Previously, spectroscopic optical monitoring (“near-infrared spectroscopy” (NIRS)) has been used for transcranial measurements of total hemoglobin concentration (THC), blood oxygen saturation [17

17. A. Villringer and B. Chance, “Non-invasive optical spectroscopy and imaging of human brain function,” Trends Neurosci. 20, 435–442 (1997). [CrossRef] [PubMed]

, 18

18. E. M. C. Hillman, “Optical brain imaging in vivo: techniques and applications from animal to man,” Journal of Biomedical Optics 12(5) (2007). [CrossRef] [PubMed]

], and, indirectly, for CBF monitoring using an exogenous tracer [19

19. W. M. Kuebler, “How NIR is the future in blood flow monitoring?” J Appl Physiol 104(4), 905–906 (2008). [CrossRef] [PubMed]

]. In stroke patients, NIRS studies [20

20. R. Carandang and D. W. Krieger, “Near infrared spectroscopy: finding utility in malignant hemispheric stroke,” Neurocritical Care 6(3), 161–164 (2007). [CrossRef] [PubMed]

] have explored detection of hemispheric CBF and oxygenation reduction [19

19. W. M. Kuebler, “How NIR is the future in blood flow monitoring?” J Appl Physiol 104(4), 905–906 (2008). [CrossRef] [PubMed]

, 21–23

21. C. Terborg, S. Bramer, S. Harscher, M. Simon, and O. W. Witte, “Bedside assessment of cerebral perfusion reductions in patients with acute ischaemic stroke by near-infrared spectroscopy and indocyanine green,” J Neurol Neurosurg Psychiatry 75(1), 38–42 (2004). [PubMed]

], cerebrovascular reactivity [24

24. F. Vernieri, N. Rosato, F. Pauri, F. Tibuzzi, F. Passarelli, and P. M. Rossini, “Near Infrared Spectroscopy and Transcranial Doppler in Monohemispheric Stroke,” Eur Neurol 41(3), 159–162 (1999). [CrossRef] [PubMed]

, 25

25. P. Bönöczk, G. Panczel, and Z. Nagy, “Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study,” European Journal of Ultrasound 15(1–2), 85–91 (2002). [CrossRef] [PubMed]

], and local functional changes [26–28

26. K. Sakatani, Y. Xie, W. Lichty, S. Li, and H. Zuo, “Language-Activated Cerebral Blood Oxygenation and Hemodynamic Changes of the Left Prefrontal Cortex in Poststroke Aphasic Patients : A Near-Infrared Spectroscopy Study,” Stroke 29(7), 1299–1304 (1998). [CrossRef] [PubMed]

]. Some studies have shown utility for monitoring acute ischemic stroke longitudinally [29

29. M. S. Damian and R. Schlosser, “Bilateral near infrared spectroscopy in space-occupying middle cerebral artery stroke,” Neurocritical Care 6(3), 165–173 (2007). [CrossRef] [PubMed]

], providing information complementary to the macrovascular CBF obtained with TCD [24

24. F. Vernieri, N. Rosato, F. Pauri, F. Tibuzzi, F. Passarelli, and P. M. Rossini, “Near Infrared Spectroscopy and Transcranial Doppler in Monohemispheric Stroke,” Eur Neurol 41(3), 159–162 (1999). [CrossRef] [PubMed]

]. Hargroves et al [30

30. D. Hargroves, R. Tallis, V. Pomeroy, and A. Bhalla, “The influence of positioning upon cerebral oxygenation after acute stroke: a pilot study,” Age Ageing 37(5), 581–585 (2008). [CrossRef] [PubMed]

] have shown that NIRS is able to detect changes in blood oxygen saturation during postural alterations in stroke patients.

“Diffuse correlation spectroscopy” (DCS) (or “diffusing wave spectroscopy” (DWS)) [31–34

31. D. A. Boas, L. E. Campbell, and A. G. Yodh, “Scattering and Imaging with Diffusing Temporal Field Correlations,” Phys Rev Lett 75(9), 1855–1858 (1995). [CrossRef] [PubMed]

] is a novel technique that has been applied to characterize blood flow in deep tissues. DCS uses the temporal intensity fluctuations of scattered light to probe CBF. It shares the light penetration advantages of NIRS but provides a much more direct measure of CBF [35–37

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

]. The technique has been extensively validated in vivo, in tissues, including comparisons with laser Doppler flowmetry (LDF) [35

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

] , Doppler ultrasound (DU) [35

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

, 38–40

38. G. Yu, T. Durduran, C. Zhou, H. W. Wang, M. E. Putt, M. Saunders, C. M. Seghal, E. Glatstein, A. G. Yodh, and T. M. Busch, “Noninvasive Monitoring of Murine Tumor Blood Flow During and After Photodynamic Therapy Provides Early Assessment of Therapeutic Efficacy,” Clin. Cancer Res. 11, 3543–3552 (2005). [CrossRef] [PubMed]

], arterial-spin labeled MRI (ASL-MRI) [35

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

, 36

36. T. Durduran, G. Yu, M. G. Burnett, J. A. Detre, J. H. Greenberg, J. Wang, C. Zhou, and A. G. Yodh, “Diffuse Optical Measurements of Blood Flow, Blood Oxygenation and Metabolism in Human Brain during Sensorimotor Cortex Activation,” Opt Lett 29, 1766–1768 (2004). [CrossRef] [PubMed]

, 41–44

41. T. Durduran, M. N. Kim, E. M. Buckley, R. Choe, C. Zhou, G. Y. Yu, and A. G. Yodh, “Validation of diffuse correlation spectroscopy for measurement of cerebral blood flow across spatial scales and against multiple modalities,” in SPIE Photonics West (San Jose, CA, 2009).

], Xenon-CT [45

45. M. N. Kim, T. Durduran, S. Frangos, E. M. Buckley, C. Zhou, G. Yu, H. Moss, B. L. Edlow, E. Maloney-Wilensky, J. A. Detre, J. H. Greenberg, W. A. Kofke, A. G. Yodh, M. S. Grady, J. H. Woo, R. L. Wolf, and J. Levine, “Validation Of Diffuse Correlation Spectroscopy Against Xenon CTCBF In Humans After Traumatic Brain Injury or Subarachnoid Hemorrhage,” in Neurocritical Care Society Annual Meeting (Miami, FL, 2008).

], fluorescent microsphere measurement of CBF [46

46. T. Durduran, M. N. Kim, E. M. Buckley, C. Zhou, G. Yu, R. Choe, J. H. Greenberg, J. A. Detre, and A. G. Yodh, “Diffuse Optical Monitoring of Cerebral Oxygen Metabolism at the Bed-Side in Cerebrovascular Disorders,” in OSA: Annual Meeting, Frontiers in Optics 2008 (Rochester, NY, 2008).

, 47

47. C. Zhou, S. Eucker, T. Durduran, G. Yu, J. Ralston, S. Friess, R. Ichor, S. Margulies, and A. G. Yodh, “Diffuse Optical Monitoring of Hemodynamic Changes in Piglet Brain with Closed Head Injury,” Journal of Neurotrauma submitted (2009).

], and against expectations from invasive and non-invasive measures of physiology [35–37

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

, 48–50

48. J. P. Culver, T. Durduran, D. Furuya, C. Cheung, J. H. Greenberg, and A. G. Yodh, “Diffuse Optical Tomography of Cerebral Blood Flow, Oxygenation and Metabolism in Rat During Focal Ischemia,” J. Cereb. Blood Flow Metab. 23, 911–24 (2003). [CrossRef] [PubMed]

]. Recently, its clinical feasibility as a bed-side monitor was also tested for assessing cerebral autoregulation in acute stroke [51–53

51. T. Durduran, M. N. Kim, E. M. Buckley, B. L. Edlow, H. Moss, C. Zhou, G. Yu, R. Choe, S. K. Frangos, E. Wilensky-Mahoney, A. Kofke, J. M. Levine, R. L. Wolf, J. Woo, S. E. Kasner, B. L. Cucchiara, M. E. Putt, A. G. Yodh, J. H. Greenberg, and J. A. Detre, “Bedside Monitoring of Cerebral Hemodynamics for Stroke and Neurocritical Care Using Novel Diffuse Optical Probes,” in Annual Meeting of the American Neurological Association, p. Abstract 298 (American Neurological Association, Salt Lake City, Utah, 2008).

], in traumatic brain injury [45

45. M. N. Kim, T. Durduran, S. Frangos, E. M. Buckley, C. Zhou, G. Yu, H. Moss, B. L. Edlow, E. Maloney-Wilensky, J. A. Detre, J. H. Greenberg, W. A. Kofke, A. G. Yodh, M. S. Grady, J. H. Woo, R. L. Wolf, and J. Levine, “Validation Of Diffuse Correlation Spectroscopy Against Xenon CTCBF In Humans After Traumatic Brain Injury or Subarachnoid Hemorrhage,” in Neurocritical Care Society Annual Meeting (Miami, FL, 2008).

, 51

51. T. Durduran, M. N. Kim, E. M. Buckley, B. L. Edlow, H. Moss, C. Zhou, G. Yu, R. Choe, S. K. Frangos, E. Wilensky-Mahoney, A. Kofke, J. M. Levine, R. L. Wolf, J. Woo, S. E. Kasner, B. L. Cucchiara, M. E. Putt, A. G. Yodh, J. H. Greenberg, and J. A. Detre, “Bedside Monitoring of Cerebral Hemodynamics for Stroke and Neurocritical Care Using Novel Diffuse Optical Probes,” in Annual Meeting of the American Neurological Association, p. Abstract 298 (American Neurological Association, Salt Lake City, Utah, 2008).

, 54

54. M. N. Kim, T. Durduran, S. Frangos, E. M. Buckley, C. Zhou, G. Yu, B. L. Edlow, E. Mahoney-Wilensky, S. M. Grady, J. Levine, J. A. Detre, J. H. Greenberg, and A. G. Yodh, “Diffuse Optical Measurements of Cerebral Blood Flow and Oxygenation in Patients after Traumatic Brain Injury or Subarachnoid Hemhorrage,” in OSA Biomedicals Topicals, p. CN237 (St Petersburg, FL, 2008).

] and in measuring the carbon dioxide reactivity of neonates with congenital heart defects [42

42. T. Durduran, C. Zhou, M. N. Kim, E. M. Buckley, G. Yu, R. Choe, S. M. Durning, S. Mason, L. M. Montenegro, S. C. Nicholson, R. A. Zimmerman, J. J. Wang, J. A. Detre, A. G. Yodh, and D. J. Licht, “Validation of Diffuse Correlation Spectroscopy for Non-Invasive, Continuous Monitoring of CBF in Neonates with Congenital Heart Defects,” in Annual Meeting of the American Neurological Association, p. Abstract 299 (American Neurological Association, Salt Lake City, Utah, 2008).

, 43

43. T. Durduran, C. Zhou, G. Yu, R. Choe, D. Silvestre, J. J. Wang, S. Nicolson, L. Montenegro, J. A. Detre, A. G. Yodh, and D. Licht, “Preoperative measurement of CO2 reactivity and cerebral autoregulation in neonates with severe congenital heart defects,” in SPIE Photonics West (San Jose, CA, 2007).

]. In other clinical problems, the feasibility of DCS has been demonstrated for monitoring diseased and healthy human muscle [44

44. G. Yu, T. Floyd, T. Durduran, C. Zhou, J. J. Wang, J. A. Detre, and A. G. Yodh, “Validation of diffuse correlation spectroscopy for muscle blood flow with concurrent arterial-spin-labeling perfusion,” Opt Exp 15, 1064–75 (2007). [CrossRef]

, 55

55. G. Yu, T. Durduran, G. Lech, C. Zhou, B. Chance, E. R. Mohler, and A. G. Yodh, “Time-dependent Blood Flow and Oxygenation in Human Skeletal Muscle Measured with Noninvasive Near-infrared Diffuse Optical Spectroscopies,” J Biomed Opt 10(3), 024,027–1–12 (2005). [CrossRef]

], for monitoring prostate, lung, breast and head & neck cancers of humans [56–58

56. G. Yu, T. Durduran, C. Zhou, T. C. Zhu, J. C. Finlay, T. M. Busch, S. B. Malkowicz, S. M. Hahn, and A. G. Yodh, “Real-time In situ Monitoring of Human Prostate Photodynamic Therapy with Diffuse Light,” Photochem Photobiol 82, 1279–84 (2006). [CrossRef] [PubMed]

] and cancer models in animals [38

38. G. Yu, T. Durduran, C. Zhou, H. W. Wang, M. E. Putt, M. Saunders, C. M. Seghal, E. Glatstein, A. G. Yodh, and T. M. Busch, “Noninvasive Monitoring of Murine Tumor Blood Flow During and After Photodynamic Therapy Provides Early Assessment of Therapeutic Efficacy,” Clin. Cancer Res. 11, 3543–3552 (2005). [CrossRef] [PubMed]

, 40

40. C. Menon, G. M. Polin, I. Prabakaran, A. Hs, C. Cheung, J. P. Culver, J. Pingpank, C. S. Sehgal, A. G. Yodh, D. G. Buerk, and D. L. Fraker, “An Integrated Approach to Measuring Tumor Oxygen Status using Human Melanoma Xenografts as a Model,” Cancer Res. 63, 7232–40 (2003). [PubMed]

, 59

59. U. Sunar, S. Makonnen, C. Zhou, T. Durduran, G. Yu, H. W. Wang, W. M. Lee, and A. G. Yodh, “Hemodynamic responses to antivascular therapy and ionizing radiation assessed by diffuse optical spectroscopies,” Opt. Express 15(23), 15,507–15,516 (2007). [CrossRef]

, 60

60. T. Durduran, R. Choe, G. Yu, C. Zhou, J. C. Tchou, B. J. Czerniecki, and A. G. Yodh, “Diffuse Optical Measurement of Blood flow in Breast Tumors,” Opt Lett 30, 2915–17 (2005). [CrossRef] [PubMed]

]. These developments indicate the potential of all-optical methods for continuous non-invasive estimation of cerebral metabolic rate of oxygen extraction (CMRO2) [35

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

, 36

36. T. Durduran, G. Yu, M. G. Burnett, J. A. Detre, J. H. Greenberg, J. Wang, C. Zhou, and A. G. Yodh, “Diffuse Optical Measurements of Blood Flow, Blood Oxygenation and Metabolism in Human Brain during Sensorimotor Cortex Activation,” Opt Lett 29, 1766–1768 (2004). [CrossRef] [PubMed]

, 48–50

48. J. P. Culver, T. Durduran, D. Furuya, C. Cheung, J. H. Greenberg, and A. G. Yodh, “Diffuse Optical Tomography of Cerebral Blood Flow, Oxygenation and Metabolism in Rat During Focal Ischemia,” J. Cereb. Blood Flow Metab. 23, 911–24 (2003). [CrossRef] [PubMed]

]. In total, these studies have shown that DCS can reliably provide a flow index proportional to relative changes in CBF.

Here we demonstrate the clinical potential of concurrent bedside optical CBF and THC monitoring in acute ischemic stroke patients. We hypothesized that optical probes placed on the forehead of patients with acute ischemic stroke (AIS) affecting the anterior circulation, would detect differences in autoregulatory impairment between the affected and unaffected hemispheres during head-of-bed (HOB) manipulations. The term autoregulation is used in this manuscript to describe cerebral blood flow changes with HOB positioning. We also compared findings of CBF with concurrent measurements of THC using NIRS.

Seventeen patients with AIS were recruited and studied on one or more occasions during their hospitalization. A comparison group of eight subjects with vascular risk factors was also studied on one occasion. At each time point, changes in CBF (rCBF) and THC (∆THC) from each hemisphere were measured sequentially at four HOB positions (30°, 15°, 0°, -5°, and 0°) and normalized to the value at HOB=30° (rCBF30°) for comparison between subjects and hemispheres. Throughout this manuscript, “r” denotes “relative” change (i.e. as opposed to “regional” which is sometimes employed in the literature).

Overall, this study demonstrates use of DCS on stroke patients, demonstrates DCS as a new diagnostic tool with the potential to develop into a non-invasive bed-side monitor of local microvascular CBF, and demonstrates the potential of complementary hemodynamic information available by hybridizing NIRS with DCS. DCS-NIRS probes are demonstrated to detect hemispheric differences in cerebrovascular hemodynamics using the simple bedside intervention of altering a patient’s head-of-bed (HOB) position. The ability to measure cerebrovascular hemodynamics at the bedside provides new opportunities for individualized stroke care based on each patient’s hemodynamics responses to these types of interventions. (Note, part of this data was previously published in abstract form [51–53

51. T. Durduran, M. N. Kim, E. M. Buckley, B. L. Edlow, H. Moss, C. Zhou, G. Yu, R. Choe, S. K. Frangos, E. Wilensky-Mahoney, A. Kofke, J. M. Levine, R. L. Wolf, J. Woo, S. E. Kasner, B. L. Cucchiara, M. E. Putt, A. G. Yodh, J. H. Greenberg, and J. A. Detre, “Bedside Monitoring of Cerebral Hemodynamics for Stroke and Neurocritical Care Using Novel Diffuse Optical Probes,” in Annual Meeting of the American Neurological Association, p. Abstract 298 (American Neurological Association, Salt Lake City, Utah, 2008).

]).

2. Materials and Methods

2.1. Study Design and Patient Enrollment

The AIS group consisted of patients admitted to the stroke service with radiographic evidence or clinical suspicion of acute ischemic stroke involving the frontal lobe cortex. Exclusion criteria included intracranial hemorrhage on initial CT or MRI scan and inability to lie supine for 15 minutes. Admission NIH Stroke Scale (NIHSS) was scored for each patient at the time of admission. Vascular risk factors identical to those in the VRF group were ascertained from verbal history and available medical records. Stroke etiology was classified according to the “Trial of ORG 10172 in Acute Stroke Treatment” (TOAST) criteria [61

61. H. P. Adams, B. H. Bendixen, L. J. Kappelle, J. Biller, B. B. Love, D. L. Gordon, and E. E. Marsh, “Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment,” Stroke 24(1), 35–41 (1993). [CrossRef] [PubMed]

] as large-artery atherosclerosis (LAS), small-artery occlusion (SAO), cardioembolic (CE), cryptogenic (CRYP) and other causes (OTHER). A neurologist reviewed all available head CT and brain MRI data to determine stroke (or infarct) laterality (“Stroke Lat.”), vascular territory, and region(s) of brain involved. The primary indicators for radiographic evidence of stroke were hypodensity on CT and/or diffusion restriction on diffusion MRI sequences. CT and MR angiographic data were also used to support the assessment of vascular territory involvement where available. Vessel involvement (“Vessel Inv.”) was characterized as middle cerebral artery (MCA), anterior cerebral artery (ACA). Brain region involvement (“Brain Reg. Inv.”) was characterized as frontal (F), temporal (T), parietal (P) and occipital (O). If orthostasis (“Orth. Symp.”), defined by the presence of worsening neurological symptoms with altered HOB position, was observed during the study, it was noted.

Measurements were planned for three separate days. Probes were placed on the forehead about 1.5-2 cm symmetrically left and right of the mid-line in order to avoid sinuses. The probes were held tightly onto the skin with black foam pads using medical tape and a circumferential, black elastic band. Both rCBF and ∆THC were measured in both frontal lobes for 5 minutes each at HOB angles of 30°, 15°, 0°, -5°, and 0° sequentially (Figure 1). Each probe contained one source and one detector fiber for NIRS, and one source and two detector fibers for DCS measurements. The source-detector separation was 2.5 cm for both techniques. All fibers were custom made with tips bent at 90°.

2.2. Optical Method: Background And Analysis

Near-infrared photons undergo thousands of scattering events before reaching a detector displaced 3 cm from the source fiber at the tissue surface (Figure 1). Photon absorption also occurs, mainly due to tissue oxy- and deoxy-hemoglobin, water and lipid. Scattering is dominated by cell organelles, and a detectable amount of scattering comes from red blood cells (RBCs). If photons are scattered from moving RBCs, then the diffuse light intensity on the tissue surface will fluctuate in time. The resultant fluctuations of the detected intensity are measured by DCS. NIRS measures the differential change in the transmitted light intensity at multiple wavelengths due to absorption and scattering which, in turn, depend on changes in concentrations of oxy- and deoxy-hemoglobin (∆HbO2 and ∆Hb) among other factors.

The “detection volume” depends on the tissue optical properties and the source-detector separation (Figure 1). Tissue optical properties or tissue dynamics within this volume, such as those due to CBF variation from HOB positional changes, are detectable in the decay rate of the DCS intensity auto-correlation function (g 2(τ)) (see Figure 1 for example data) or in the amplitude and phase of the diffusing wave NIRS signal. The DCS analysis employed a semi-infinite, homogeneous medium model for the head [31

31. D. A. Boas, L. E. Campbell, and A. G. Yodh, “Scattering and Imaging with Diffusing Temporal Field Correlations,” Phys Rev Lett 75(9), 1855–1858 (1995). [CrossRef] [PubMed]

, 32

32. D. A. Boas and A. G. Yodh, “Spatially varying dynamical properties of turbid media probed with diffusing temporal light correlation,” J. Opt. Soc. Am. A 14(1), 192–215 (1997). [CrossRef]

, 35

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

, 36

36. T. Durduran, G. Yu, M. G. Burnett, J. A. Detre, J. H. Greenberg, J. Wang, C. Zhou, and A. G. Yodh, “Diffuse Optical Measurements of Blood Flow, Blood Oxygenation and Metabolism in Human Brain during Sensorimotor Cortex Activation,” Opt Lett 29, 1766–1768 (2004). [CrossRef] [PubMed]

, 49

49. C. Cheung, J. P. Culver, K. Takahashi, J. H. Greenberg, and A. G. Yodh, “In vivo cerebrovascular measurement combining diffuse near-infrared absorption and correlation spectroscopies,” Phys. Med. and Biol. 46(8), 2053–2065 (2001). [CrossRef]

]. This model was iteratively fit to the measured auto-correlation functions and a flow-index for each hemisphere was extracted in seven second intervals. For NIRS, a modified Beer-Lambert equation [62

62. D. T. Delpy, M. Cope, P. van der Zee, S. Arridge, S. Wray, and J. Wyatt, “Estimation of optical pathlength through tissue from direct time of flight measurement,” Phys Med Biol 33, 1433–1442 (1988). [CrossRef] [PubMed]

, 63

63. M. Cope and D. T. Delpy, “System for long-term measurement of cerebral blood flow and tissue oxygenation on newborn infants by infra-red transillumination.” Med Biol Eng Comput 26, 289–294 (1988). [CrossRef] [PubMed]

] with assumed photon path-lengths from the literature was used to analyze data [35

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

, 36

36. T. Durduran, G. Yu, M. G. Burnett, J. A. Detre, J. H. Greenberg, J. Wang, C. Zhou, and A. G. Yodh, “Diffuse Optical Measurements of Blood Flow, Blood Oxygenation and Metabolism in Human Brain during Sensorimotor Cortex Activation,” Opt Lett 29, 1766–1768 (2004). [CrossRef] [PubMed]

]. NIRS calculations report ∆HbO2, ∆Hb and their sum relative to the 30° baseline (i.e. ∆HbO2,30°, ∆Hb30°, ∆THC30°). DCS flow indices for each HOB angle were averaged and divided by the average flow index at the 30° baseline, providing CBF relative to that at 30°, i.e. rCBF30°.

Fig. 1. Illustration of the measurement protocol (top), the probe positioning (middle), and the corresponding volume interrogated by the diffusing photons . (Bottom) Sample intensity auto-correlation data measured at HOB = 30° and -5°.

Here we present a simple outline of data analyses schemes that are described more fully in references [35

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

, 36

36. T. Durduran, G. Yu, M. G. Burnett, J. A. Detre, J. H. Greenberg, J. Wang, C. Zhou, and A. G. Yodh, “Diffuse Optical Measurements of Blood Flow, Blood Oxygenation and Metabolism in Human Brain during Sensorimotor Cortex Activation,” Opt Lett 29, 1766–1768 (2004). [CrossRef] [PubMed]

, 49

49. C. Cheung, J. P. Culver, K. Takahashi, J. H. Greenberg, and A. G. Yodh, “In vivo cerebrovascular measurement combining diffuse near-infrared absorption and correlation spectroscopies,” Phys. Med. and Biol. 46(8), 2053–2065 (2001). [CrossRef]

].

2.2.1. Differential pathlength method for NIRS:

In order to estimate oxy- and deoxy-hemoglobin concentration changes in a rapid and simple manner we employed the so-called “differential pathlength method” [64–66

64. P. van der Zee, M. Cope, S. R. Arridge, M. Essenpreis, L. A. Potter, A. D. Edwards, J. S. Wyatt, D. C. McCormick, S. C. Toth, E. O. R. Reynolds, and D. T. Delpy, “Experimentally measured optical pathlengths for the adult’s head, calf and forearm and the head of the newborn infant asa function of interoptode spacing,” Adv. Exp. Med. Biol. 316, 143–153 (1992). [CrossRef] [PubMed]

]. This formulation can be derived approximately from the diffusion equation approach using Green’s function solutions (in our case, in the semi-infinite, homogeneous geometry) [67

67. S. R. Arridge, M. Cope, and D. T. Delpy, “The theoretical basis for the determination of optical pathlengths in tissue: temporal and frequency analysis,” Phys Med Biol 37(7), 1531–60 (1992). [CrossRef] [PubMed]

]. In this formulation, the standard Beer-Lambert law is modified to account for the lengthening of the mean photon pathlength due to scattering and absorption effects in tissue. A “differential pathlength factor” (DPF) is introduced, which is the ratio of the mean photon pathlength to the physical separation of the source-detector pair. The DPF depends on experimental conditions such as geometry and wavelength and has minimal dependence on source-detector separation for large (~2 cm) separations [66

66. M. Kohl, C. Nolte, H. R. Heekeren, S. Horst, U. Scholz, H. Obrig, and A. Villringer, “Determination of the wavelength dependence of the differential pathlength factor from near-infrared pulse signals,” Phys Med Biol 43(6), 1771–82 (1998). [CrossRef] [PubMed]

]. Let I(t,λ) be the light intensity measured by the source-detector pair at time, t, and employing light with wavelength (λ). Furthermore, let I 0(<t 30° >,λ) be the average intensity measured by the same source-detector pair and wavelength on the same subject with the HOB at 30°. The differential pathlength approach relates changes in attenuation, ΔA(t,λ)=lnI(t,λ)I0(<t30°>,λ), to the change in tissue absorption (∆μa(t, λ)) between measurement states, i.e.

ΔA(t,λ)=lnI(t,λ)I0(<t30°>,λ)=Δμa(t,λ)DPF(λ)r.
(1)

Here r is the source-detector separation and the subscript “0” is used to denote the baseline measurement. ∆Hb30° and ∆HbO2,30° concentration changes can be calculated from ∆μa(λ) at several wavelengths, using values from the literature for the extinction coefficients of (ϵHb(λ), ϵHbO2(λ)) [68

68. Compiled by Scott Prahl, Online: http://omlc.ogi.edu/spectra/hemoglobin/summary.html.

] and the DPF values for an average, healthy adult head (DPF(λ 690)=6.5, DPF(λ 785)=6.4, DPF(λ 830)=5.8) [64

64. P. van der Zee, M. Cope, S. R. Arridge, M. Essenpreis, L. A. Potter, A. D. Edwards, J. S. Wyatt, D. C. McCormick, S. C. Toth, E. O. R. Reynolds, and D. T. Delpy, “Experimentally measured optical pathlengths for the adult’s head, calf and forearm and the head of the newborn infant asa function of interoptode spacing,” Adv. Exp. Med. Biol. 316, 143–153 (1992). [CrossRef] [PubMed]

, 65

65. A. Duncan, J. H. Meek, M. Clemence, C. E. Elwell, L. Tyszczuk, M. Cope, and D. T. Delpy, “Optical pathlength measurements on adult head, calf and forearm and the head of the newborn infant using phase resolved optical spectroscopy,” Phys. Med. Biol. 40(2), 295–304. (1995). [CrossRef] [PubMed]

] . Hemoglobin concentration changes are calculated by solving the following matrix equation at each time point;

[Δμa(λ1,t)Δμa(λ2,t)]=[Hb(λ1,t)HbO2(λ1,t)Hb(λ2,t)HbO2(λ2,t)][ΔHb(t)ΔHbO2(t)].
(2)

In our case, we use all three wavelengths to improve the signal-to-noise ratio and reduce the effect of fluctuations due to erratic fluctuations of a single laser. A substantial literature exists on the weaknesses and strengths of this formulation [66

66. M. Kohl, C. Nolte, H. R. Heekeren, S. Horst, U. Scholz, H. Obrig, and A. Villringer, “Determination of the wavelength dependence of the differential pathlength factor from near-infrared pulse signals,” Phys Med Biol 43(6), 1771–82 (1998). [CrossRef] [PubMed]

, 69–72

69. G. Strangman, M. A. Franceschini, and D. A. Boas, “Factors affecting the accuracy of near-infrared spectroscopy concentration calculations for focal changes in oxygenation parameters,” NeuroImage 18, 865–79 (2003). [CrossRef] [PubMed]

], and experimental tabulations of the differential pathlength factor, DPF, are available for several organs [64

64. P. van der Zee, M. Cope, S. R. Arridge, M. Essenpreis, L. A. Potter, A. D. Edwards, J. S. Wyatt, D. C. McCormick, S. C. Toth, E. O. R. Reynolds, and D. T. Delpy, “Experimentally measured optical pathlengths for the adult’s head, calf and forearm and the head of the newborn infant asa function of interoptode spacing,” Adv. Exp. Med. Biol. 316, 143–153 (1992). [CrossRef] [PubMed]

, 65

65. A. Duncan, J. H. Meek, M. Clemence, C. E. Elwell, L. Tyszczuk, M. Cope, and D. T. Delpy, “Optical pathlength measurements on adult head, calf and forearm and the head of the newborn infant using phase resolved optical spectroscopy,” Phys. Med. Biol. 40(2), 295–304. (1995). [CrossRef] [PubMed]

]. It is beyond the scope of this paper to discuss more of the details of this commonly employed formulation. The resultant ∆μa(t,λ) at 785nm is used in DCS analysis to include the (minimal) effects of changes in absorption over time on the correlation function measurements.

2.2.2. Semi-infinite approximation for DCS:

In most flow experiments the fundamental quantity of interest is the electric field (E(r,t)) temporal autocorrelation function G 1(r,t,τ) = 〈E(r,t) E *(r, t + τ)〉 or its Fourier Transform. Here the angle brackets 〈 〉 denote ensemble averages or averages over time for actual measurements. τ is called the correlation or delay time. In this study, the solutions for the photon correlation diffusion equation in a semi-infinite geometry were employed [31

31. D. A. Boas, L. E. Campbell, and A. G. Yodh, “Scattering and Imaging with Diffusing Temporal Field Correlations,” Phys Rev Lett 75(9), 1855–1858 (1995). [CrossRef] [PubMed]

, 32

32. D. A. Boas and A. G. Yodh, “Spatially varying dynamical properties of turbid media probed with diffusing temporal light correlation,” J. Opt. Soc. Am. A 14(1), 192–215 (1997). [CrossRef]

, 35

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

, 36

36. T. Durduran, G. Yu, M. G. Burnett, J. A. Detre, J. H. Greenberg, J. Wang, C. Zhou, and A. G. Yodh, “Diffuse Optical Measurements of Blood Flow, Blood Oxygenation and Metabolism in Human Brain during Sensorimotor Cortex Activation,” Opt Lett 29, 1766–1768 (2004). [CrossRef] [PubMed]

, 49

49. C. Cheung, J. P. Culver, K. Takahashi, J. H. Greenberg, and A. G. Yodh, “In vivo cerebrovascular measurement combining diffuse near-infrared absorption and correlation spectroscopies,” Phys. Med. and Biol. 46(8), 2053–2065 (2001). [CrossRef]

]

G1(r,t,τ)=3μs4π(eK(t,τ)rreK(t,τ)r2r2),
(3)

where r is the source-detector separation and r2=r2+(zo+2zb)2 is the separation between an “image source” and the detector, zo=1μs is equal to the random walk step, zb=23μs1+Reff1Reff is the distance of an imaginary boundary, Reff is the reflection coefficient which depends on the ratio of the indices of refraction of tissue and air, K2(t,τ)=(μa(t,λ785)+13αμsk02<Δr2(t,τ)>)/(3μs),μs is the tissue reduced scattering coefficient (assumed to be constant over time), k 0 is the wavevector of the photons in the tissue, 〈∆rs 2(t,τ)〉 is the mean-square displacement in time τ of the scattering particles (i.e. red blood cells), and a represents the fraction of photon scattering events in tissue from moving cells.

g2(r,t,τ)=1+βg1(r,t,τ)2.
(4)

β is a parameter that depends on the source coherence, detection optics, ambient light and other external factors. In our experiments, β is allowed to be time dependent and is fitted and calculated from the measured data. While we see small variations in β of less than 0.1, accounting for them reduces signal fluctuations (unpublished phantom data).

The correlation diffusion equation can have different forms depending on the nature of the particle motion, and on the variations of these motions with position in the sample. We use a formulation wherein the mean-square displacement 〈∆rs 2(t,τ)〉 = 6DB(t)τ, red blood cells are taken to undergo an “effective” Brownian motion with a diffusion coefficient DB. Note DB is not the particle diffusion coefficient due to standard Brownian motion described by Einstein [73

73. A. Einstein, “On the motion of small particles suspended in liquids at rest required by the molecular-kinetic theory of heat,” Annalen der Physik 17, 549–60 (1905). [CrossRef]

]. We then fit the measured autocorrelation function using Equation 3 for a “blood flow index” (i.e. BFI(t) = αDB(t)). As discussed in Section 1, we have previously shown that changes in a fitted BFI(t) measure changes in CBF relatively accurately.

2.3. Instrumentation

A portable custom-built instrument was employed [35

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

, 49

49. C. Cheung, J. P. Culver, K. Takahashi, J. H. Greenberg, and A. G. Yodh, “In vivo cerebrovascular measurement combining diffuse near-infrared absorption and correlation spectroscopies,” Phys. Med. and Biol. 46(8), 2053–2065 (2001). [CrossRef]

]. DCS uses a long coherence length laser (785 nm). Three lasers (690nm, 785nm, 830nm) modulated at 70 MHz were used for NIRS. For DCS, the output of four high sensitivity avalanche photo-diode detectors operating in photon-counting mode were fed to a correlator board which computed the intensity auto-correlation functions in real time. For NIRS, a homodyne detection scheme with two detector channels was used [35

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

, 49

49. C. Cheung, J. P. Culver, K. Takahashi, J. H. Greenberg, and A. G. Yodh, “In vivo cerebrovascular measurement combining diffuse near-infrared absorption and correlation spectroscopies,” Phys. Med. and Biol. 46(8), 2053–2065 (2001). [CrossRef]

].

The data acquisition was interleaved between NIRS and DCS. For each probe, first NIRS data was acquired for 0.5 seconds, then DCS data was acquired for 3 seconds. This gives a total of 7 seconds of measurement time per data point since there are two probes. The fitted results reflect the mid-point of the acquisition period with respect to the start of the study.

2.4. Statistical Analysis

Data for each parameter was stored as a continuous variable over time. The data was then averaged for the last four minutes of each HOB position to avoid potential transient effects. On a few occasions, the patient condition changed transiently (e.g. the patient spoke), and we have carefully marked and avoided those times in our averaging. This averaged data was used in the statistical analysis.

To estimate and test for changes in mean rCBF and hemoglobin concentrations, we fit a linear mixed effects (LME) model (library “nlme” in R, http://www.r-project.org) [74

74. J. C. Pinheiro and D. M. Bates, Mixed-effects models in S and S-Plus (Springer, New York, 2000). [CrossRef]

], accounting for correlations between repeated measurements for each patient. Tests of relevant coefficients from the model were two-sided and used a Type I error rate of 0.05. We assessed changes in mean rCBF and mean hemoglobin concentrations as a function of three factors: HOB angle, the presence of an infarction in a given hemisphere, and the number of days since reported stroke onset (NDAY). The variability was modeled as a function of the side of infarction based on analysis of residuals and the Akaike Information Criteria [75

75. H. Akaike, “A new look at the statistical model identification,” Automatic Control, IEEE Transactions on 19(6), 716–723 (1974). [CrossRef]

]. Significance factors of interest were assessed using a likelihood ratio test for appropriate nester models.

To assess the measurement repeatability for individual patients, the correlation coefficient (R) between paired measurements at a HOB of 0° was calculated. Clinical data were described using mean±standard error.

Table 1. Detailed patient characteristics (see Section 2.1 for details).

table-icon
View This Table
| View All Tables
Fig. 2. Variation in CBF due to HOB positioning on first study day from peri- and contra-infarct hemispheres are shown for all patients (different color per patient)

3. Results

Reliable measurements were obtained from all subjects. Figure 1 shows typical measured temporal auto-correlation functions with a faster decay rate when the HOB is lowered from 30° to -5°, indicating an increase in CBF.

The seventeen AIS patients aged between 44 and 93 years (65±16), with admission NIHSS score from 2 to 26 (15±8). The mean number of days since reported stroke onset (NDAY) for the first optical study was 2.2±0.8 days. The middle cerebral artery (MCA) territory only was involved in 14 cases while the anterior cerebral artery territory was also involved in 3 additional cases. Orthostatic symptoms were present in three patients. Patient details are summarized in Table 1 and statistical findings from the optical data in Table 2.

rCBF30° in the AIS group showed a large variability between subjects, presumably due to differences in their clinical condition. Figure 2 shows variations in CBF with positioning on the first study day for all patients. Results from subsequent days had similar levels of variability (data not shown).

Repeated measurements at flat HOB, i.e. when lowering from 15° and when raising from -5°, showed a strong correlation to initial value (R=0.96), indicating excellent repeatability within each study day (R=0.96). HOB positioning was significantly associated with changes in frontal hemispheric rCBF30° in both infarct (p=0.008) and non-infarct (p=0.005) hemispheres. The presence of an “infarct” in a given hemisphere was significantly associated with increased variability in rCBF30° versus HOB position (p=0.02). Figure 3(a) shows one representative result on the third day after stroke onset from a 70 year old female with a right MCA occlusion. During rest periods between changes of HOB, the variations in measured rCBF30° were smaller than changes due to HOB angle, and a large discrepancy was observed between hemispheres.

Similarly, ∆HbO2,30°, ∆Hb30° and ∆THC30° in the AIS group showed a large variability between subjects but with excellent repeatability (R=0.94). Unlike rCBF30°, the HOB effect on ∆HbO2,30° and ∆THC30° was significant only in the infarct (p=0.004 and p=0.03) but not in the non-infarct (p=0.15 and p=0.4) hemisphere. ∆Hb30° was not significant in either hemisphere (p=0.6 and p=0.9). Nevertheless, the presence of an “infarct” in a given hemisphere was significantly associated with increased variability for all quantities. These findings are in qualitative agreement with rCBF30° findings. NIRS data is, however, harder to interpret since local changes in oxy- and deoxy-hemoglobin concentration are dependent on complex parameters such as the local oxygen extraction fraction. Figure 3(b) shows ∆THC30° from the same patient. During rest periods between changes of HOB, the variations in measured ∆THC30° are smaller than changes due to HOB angle and a very large discrepancy is observed between the infarct and non-infarct hemispheres.

Table 2. Statistical findings in acute ischemic stroke (AIS) group. SEM=Standard Error of Mean. Bold font implies statistical significance .

table-icon
View This Table
| View All Tables
Fig. 3. (a) rCBF30° and (b) ∆THC30° as a function of time with HOB angle from a patient with right MCA occlusion. HOB position is a significant factor in both hemispheres, but a larger effect is observed in the infarct (right) hemisphere. Blue(gray) indicate left(right) hemispheres.

Several measurements were conducted in each patient between 1 and 11 days post-stroke. To consider the effect of NDAY, we categorized each measurement as occurring between 1-2, 3-4, or >4 days after the reported stroke onset. We anticipated that NDAY might have a larger effect on the infarct hemisphere than on the non-infarct hemisphere, but this was not observed. Bi-variate analysis (including NDAY with HOB) did not change our conclusions.

We note that approximately 75% of the patients had maximal CBF and THC at 0° or -5°. However, four (~25%) patients exhibited maximal CBF and THC at HOB>0° which we denote as being “paradoxical”.

Eight subjects were enrolled in the control VRF group (mean age 64 years). Both hemispheres showed similar rCBF30° response to changes in HOB angle. At a given angle, the variations in rCBF30° due to physiology and instrumental noise were smaller than changes due to HOB angle (Figure 4(a)). The ∆THC30° results agree qualitatively with rCBF30° (Figure 4(b)). As expected, there is no statistical difference between two hemispheres (p=0.57) with rCBF30° depending equally strongly on HOB angle (p=0.0001). Repeated measurements at flat HOB, i.e. when lowering from 15° and when raising from -5°, showed a strong correlation to initial value (R=0.95), confirming measurement reproducibility. Similar results where obtained with THC but without achieving significance with HOB changes.

Finally, in an analysis comparing randomly selected hemispheres for all subjects in the VRF group to the infarcted hemispheres for all subjects in the AIS group, a statistically significant difference was observed between the two groups for rCBF30° (p=0.02) and for ∆THC30° (p=0.0001).

Fig. 4. rCBF30° (a) and ∆THC30° (b) changes over time with HOB angle in a subject with vascular risk factors. Blue(gray) lines indicate left(right) hemispheres. Thick vertical bars indicate HOB changes to the labeled angle.

4. Discussion

This study demonstrates the feasibility of hybrid DCS-NIRS technology for monitoring differences in autoregulatory impairment between the affected and unaffected hemispheres in acute stroke patients. As predicted, the presence of an ischemic infarct was significantly associated with changes in ipsilateral rCBF30° as HOB positions varied. In addition, repeat measurements at 0° HOB showed a high degree of intra-subject repeatability (R>0.9), suggesting that DCS provides reproducible measurements of CBF. These findings provide the first demonstration of DCS as an effective modality for measuring changes of CBF in acute stroke patients, building upon prior studies that used DCS to measure CBF in healthy human subjects [35

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

, 36

36. T. Durduran, G. Yu, M. G. Burnett, J. A. Detre, J. H. Greenberg, J. Wang, C. Zhou, and A. G. Yodh, “Diffuse Optical Measurements of Blood Flow, Blood Oxygenation and Metabolism in Human Brain during Sensorimotor Cortex Activation,” Opt Lett 29, 1766–1768 (2004). [CrossRef] [PubMed]

].

A key observation was the variable impact of acute ischemic stroke on cerebrovascular autoregulation. While the results for the VRF (control) group were similar between individuals and did not show any significant variations in rCBF30° response between hemispheres, the AIS group showed a large variability between subjects. Most importantly, for the AIS group a statistically significant difference was observed between infarct and non-infarct hemispheres. For the AIS group, the majority of patients displayed maximal CBF at a HOB angle of 0° to -5°, while approximately 25% exhibited maximal CBF at an elevated HOB angle of 15° to 30°. All subjects of the VRF group, however, showed maximal CBF at -5°. The basis for a paradoxical response is uncertain, but could be due to elevated intracranial pressure (ICP), hemodynamic consequences of heart failure, or autonomic dysfunction. Similar paradoxical responses have been previously reported in traumatic brain injury [76

76. A. Chieregato, A. Tanfani, C. Compagnone, R. Pascarella, L. Targa, and E. Fainardi, “Cerebral blood flow in traumatic contusions is predominantly reduced after an induced acute elevation of cerebral perfusion pressure,” Neurosurgery 60(1), 115–123 (2007). [CrossRef] [PubMed]

]. Close examination of a recent work that used NIRS to monitor blood oxygen saturation during postural changes in acute stroke patients reveal a paradoxical response and large intra-subject variability in line with our results [30

30. D. Hargroves, R. Tallis, V. Pomeroy, and A. Bhalla, “The influence of positioning upon cerebral oxygenation after acute stroke: a pilot study,” Age Ageing 37(5), 581–585 (2008). [CrossRef] [PubMed]

].

Although measurements of ICP and cerebral perfusion pressure (CPP) were not available in our patients, and the precise mechanism for the paradoxical responses could not be determined, these findings suggest that flat HOB may not represent the optimum therapy for all patients with acute hemispheric stroke. We note that DCS results were recently compared to changes in ICP and CPP during HOB changes in traumatic brain injury patients indicating a close correlation between hemodynamic parameters measured by DCS-NIRS and perfusion pressures (ICP and CPP) in instances of damagedautoregulation [45

45. M. N. Kim, T. Durduran, S. Frangos, E. M. Buckley, C. Zhou, G. Yu, H. Moss, B. L. Edlow, E. Maloney-Wilensky, J. A. Detre, J. H. Greenberg, W. A. Kofke, A. G. Yodh, M. S. Grady, J. H. Woo, R. L. Wolf, and J. Levine, “Validation Of Diffuse Correlation Spectroscopy Against Xenon CTCBF In Humans After Traumatic Brain Injury or Subarachnoid Hemorrhage,” in Neurocritical Care Society Annual Meeting (Miami, FL, 2008).

, 51

51. T. Durduran, M. N. Kim, E. M. Buckley, B. L. Edlow, H. Moss, C. Zhou, G. Yu, R. Choe, S. K. Frangos, E. Wilensky-Mahoney, A. Kofke, J. M. Levine, R. L. Wolf, J. Woo, S. E. Kasner, B. L. Cucchiara, M. E. Putt, A. G. Yodh, J. H. Greenberg, and J. A. Detre, “Bedside Monitoring of Cerebral Hemodynamics for Stroke and Neurocritical Care Using Novel Diffuse Optical Probes,” in Annual Meeting of the American Neurological Association, p. Abstract 298 (American Neurological Association, Salt Lake City, Utah, 2008).

, 54

54. M. N. Kim, T. Durduran, S. Frangos, E. M. Buckley, C. Zhou, G. Yu, B. L. Edlow, E. Mahoney-Wilensky, S. M. Grady, J. Levine, J. A. Detre, J. H. Greenberg, and A. G. Yodh, “Diffuse Optical Measurements of Cerebral Blood Flow and Oxygenation in Patients after Traumatic Brain Injury or Subarachnoid Hemhorrage,” in OSA Biomedicals Topicals, p. CN237 (St Petersburg, FL, 2008).

]. Furthermore, paradoxical responses similar to those observed in the AIS group reported here were confirmed in this patient group [45

45. M. N. Kim, T. Durduran, S. Frangos, E. M. Buckley, C. Zhou, G. Yu, H. Moss, B. L. Edlow, E. Maloney-Wilensky, J. A. Detre, J. H. Greenberg, W. A. Kofke, A. G. Yodh, M. S. Grady, J. H. Woo, R. L. Wolf, and J. Levine, “Validation Of Diffuse Correlation Spectroscopy Against Xenon CTCBF In Humans After Traumatic Brain Injury or Subarachnoid Hemorrhage,” in Neurocritical Care Society Annual Meeting (Miami, FL, 2008).

, 51

51. T. Durduran, M. N. Kim, E. M. Buckley, B. L. Edlow, H. Moss, C. Zhou, G. Yu, R. Choe, S. K. Frangos, E. Wilensky-Mahoney, A. Kofke, J. M. Levine, R. L. Wolf, J. Woo, S. E. Kasner, B. L. Cucchiara, M. E. Putt, A. G. Yodh, J. H. Greenberg, and J. A. Detre, “Bedside Monitoring of Cerebral Hemodynamics for Stroke and Neurocritical Care Using Novel Diffuse Optical Probes,” in Annual Meeting of the American Neurological Association, p. Abstract 298 (American Neurological Association, Salt Lake City, Utah, 2008).

, 54

54. M. N. Kim, T. Durduran, S. Frangos, E. M. Buckley, C. Zhou, G. Yu, B. L. Edlow, E. Mahoney-Wilensky, S. M. Grady, J. Levine, J. A. Detre, J. H. Greenberg, and A. G. Yodh, “Diffuse Optical Measurements of Cerebral Blood Flow and Oxygenation in Patients after Traumatic Brain Injury or Subarachnoid Hemhorrage,” in OSA Biomedicals Topicals, p. CN237 (St Petersburg, FL, 2008).

].

Several future methodological improvements can be anticipated based on corrections to the technical limitations of this study. We have previously shown that DCS does indeed penetrate to the cortex and measures local CBF [35

35. T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

, 36

36. T. Durduran, G. Yu, M. G. Burnett, J. A. Detre, J. H. Greenberg, J. Wang, C. Zhou, and A. G. Yodh, “Diffuse Optical Measurements of Blood Flow, Blood Oxygenation and Metabolism in Human Brain during Sensorimotor Cortex Activation,” Opt Lett 29, 1766–1768 (2004). [CrossRef] [PubMed]

]. Nevertheless, all such diffuse optical methologies hold potential for signal contamination from changes of blood flow in superficial layers such as the scalp. We note, however, that by self-normalizing data from each hemisphere to data taken at 30° elevation, we effectively ameliorate the effects of such systemic changes. Presumably, the only observable hemispheric changes to survive normalization are due to hemodynamic differences in the cortical tissue. Future studies may incorporate both small and large source-detector separations to allow separation of scalp and cortex contributions. In addition, quantification with the diffuse optical method can be improved by knowledge of skull thickness derived by CT or MRI.

In the present studies, optical probes were placed on the forehead. Accordingly, we limited our investigation to acute stroke patients whose infarct or ischemic penumbra involved the frontal lobe cortex. A follow-up study is currently underway to assess the feasibility of monitoring CBF changes in other regions. If successful, future instruments with larger probe arrays could be used to monitor CBF throughout the cortex.

While the primary aim of this study was to explore the sensitivity of DCS for detecting hemodynamic effects of HOB changes in patients with acute ischemic stroke, we also obtained concurrent NIRS data for comparison. NIRS measurements of THC and HbO2 most closely approximate CBF, and showed reasonable agreement with DCS measurements in the ischemic hemisphere. Indeed, all NIRS parameters showed more significant associations with the infarcted hemisphere than CBF by DCS, whereas only CBF showed significant HOB effects in the unaffected hemisphere and in the control group with vascular risk factors. The sensitivity of NIRS to ischemic physiology probably reflects its sensitivity to both CBF and metabolism, and the differential sensitivities of DCS and NIRS suggest that they will likely provide complementary information in the management of acute ischemic stroke and other central-nervous system disorders.

Although these data are preliminary, the observed variability in autoregulatory impairment and recovery has implications for individualized therapy in stroke management. Current guidelines from the American Stroke Association state that patients with acute, ischemic stroke should be empirically placed in a flat HOB position upon admission to the hospital. There is no formal recommendation on how long to keep a patient supine, but the authors recommend that stroke patients be observed closely during the transition to sitting and standing for any new neurological symptoms [86]. Our data suggest that this empirical approach to HOB manipulations in acute stroke patients may not be optimal for some subjects, and suggests the possibility that in the future, individualized management based on CBF monitoring could improve stroke outcomes by minimizing the risk-to-benefit ratio of hemodynamic interventions such HOB positioning, volume expansion, and hypertensive therapy. Bedside monitoring of stroke patients with DCS and NIRS may also allow changes in CBF and metabolism to be detected prior to the onset of clinical symptoms.

Acknowledgments

We acknowledge discussions with Daniel J Licht, Erin M Buckley and the staff of the Stroke unit at the Hospital of University of Pennsylvania, in particular Lauren Sansing and Larami MacKenzie for their assistance. This study was funded by NIH grants NS-045839, HL-077699, RR-02305, EB-007610, NS-60653 and University of Pennsylvania Comprehensive Neuroscience Center.

References and links

1.

A. D. Lopez, C. D. Mathers, M. Ezzati, D. T. Jamison, and C. J. L. Murray, “Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data,” The Lancet 367(9524), 1747–1757 (2006). [CrossRef]

2.

European Stroke Organization, “Recommendations for Stroke Management,” http://www.eso-stroke.org/recommendations.php?cid=9&sid=1 (Last Accessed: January 28, 2009).

3.

C. Benesch and R. Holloway, “Economic Impact of Stroke and Implications for Interventions.” CNS Drugs 9, 19 (1998). [CrossRef]

4.

L. B. Goldstein, “Should antihypertensive therapies be given to patients with acute ischemic stroke?” Drug Saf 22(1), 13–18 (2000). [CrossRef] [PubMed]

5.

S. L. Dawson, R. B. Panerai, and J. F. Potter, “Serial changes in static and dynamic cerebral autoregulation after acute ischaemic stroke,” Cerebrovasc Dis 16(1), 69–75 (2003). [CrossRef] [PubMed]

6.

K. A. Hossmann, “Viability thresholds and the penumbra of focal ischemia,” Ann Neurol 36(4), 557–565 (1994). [CrossRef] [PubMed]

7.

J. Astrup, B. K. Siesjo, and L. Symon, “Thresholds in cerebral ischemia - the ischemic penumbra,” Stroke 12(6), 723–725 (1981). [CrossRef] [PubMed]

8.

M. Wintermark, M. Sesay, E. Barbier, K. Borbely, W. P. Dillon, J. D. Eastwood, T. C. Glenn, C. B. Grandin, S. Pedraza, J. F. Soustiel, T. Nariai, G. Zaharchuk, J. M. Caille, V. Dousset, and H. Yonas, “Comparative overview of brain perfusion imaging techniques,” Stroke 36(9), 83–99 (2005). [CrossRef]

9.

J. C. Baron, “Mapping the ischaemic penumbra with PET: a new approach,” Brain 124(Pt 1), 2–4 (2001). [CrossRef] [PubMed]

10.

M. H. Mahagne, O. David, J. Darcourt, O. Migneco, A. Dunac, M. Chatel, and J. C. Baron, “Voxel-based mapping of cortical ischemic damage using Tc 99m L,L-ethyl cysteinate dimer SPECT in acute stroke,” J Neuroimaging 14(1), 23–32 (2004). [PubMed]

11.

R. E. Latchaw, “Cerebral perfusion imaging in acute stroke,” J Vasc Interv Radiol 15(1 Pt 2), 29–46 (2004).

12.

J. A. Chalela, D. C. Alsop, J. B. Gonzalez-Atavales, J. A. Maldjian, S. E. Kasner, and J. A. Detre, “Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling,” Stroke 31(3), 680–687 (2000). [CrossRef] [PubMed]

13.

C. C. Bishop, S. Powell, D. Rutt, and N. L. Browse, “Transcranial Doppler measurement of middle cerebral artery blood flow velocity: a validation study,” Stroke 17, 913–915 (1986). [CrossRef] [PubMed]

14.

R. R. Pindzola, J. R. Balzer, E. M. Nemoto, S. Goldstein, and H. Yonas, “Cerebrovascular reserve in patients with carotid occlusive disease assessed by stable xenon-enhanced ct cerebral blood flow and transcranial Doppler,” Stroke 32(8), 1811–1817 (2001). [CrossRef] [PubMed]

15.

A. V. Alexandrov, A. M. Demchuk, T. H. Wein, and J. C. Grotta, “Yield of transcranial Doppler in acute cerebral ischemia,” Stroke 30(8), 1604–1609 (1999). [CrossRef] [PubMed]

16.

S. Schwarz, D. Georgiadis, A. Aschoff, and S. Schwab, “Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke,” Stroke 33(2), 497–501 (2002). [CrossRef] [PubMed]

17.

A. Villringer and B. Chance, “Non-invasive optical spectroscopy and imaging of human brain function,” Trends Neurosci. 20, 435–442 (1997). [CrossRef] [PubMed]

18.

E. M. C. Hillman, “Optical brain imaging in vivo: techniques and applications from animal to man,” Journal of Biomedical Optics 12(5) (2007). [CrossRef] [PubMed]

19.

W. M. Kuebler, “How NIR is the future in blood flow monitoring?” J Appl Physiol 104(4), 905–906 (2008). [CrossRef] [PubMed]

20.

R. Carandang and D. W. Krieger, “Near infrared spectroscopy: finding utility in malignant hemispheric stroke,” Neurocritical Care 6(3), 161–164 (2007). [CrossRef] [PubMed]

21.

C. Terborg, S. Bramer, S. Harscher, M. Simon, and O. W. Witte, “Bedside assessment of cerebral perfusion reductions in patients with acute ischaemic stroke by near-infrared spectroscopy and indocyanine green,” J Neurol Neurosurg Psychiatry 75(1), 38–42 (2004). [PubMed]

22.

A. Liebert, H. Wabnitz, J. Steinbrink, M. Moller, R. Macdonald, H. Rinneberg, A. Villringer, and H. Obrig, “Bed-side assessment of cerebral perfusion in stroke patients based on optical monitoring of a dye bolus by time-resolved diffuse reflectance,” Neuroimage 24, 426–35 (2005). [CrossRef] [PubMed]

23.

E. Keller, G. Wietasch, P. Ringleb, M. Scholz, S. Schwarz, R. Stingele, S. Schwab, D. Hanley, and W. Hacke, “Bedside monitoring of cerebral blood flow in patients with acute hemispheric stroke,” Crit Care Med 28(2), 511–516 (2000). [CrossRef] [PubMed]

24.

F. Vernieri, N. Rosato, F. Pauri, F. Tibuzzi, F. Passarelli, and P. M. Rossini, “Near Infrared Spectroscopy and Transcranial Doppler in Monohemispheric Stroke,” Eur Neurol 41(3), 159–162 (1999). [CrossRef] [PubMed]

25.

P. Bönöczk, G. Panczel, and Z. Nagy, “Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study,” European Journal of Ultrasound 15(1–2), 85–91 (2002). [CrossRef] [PubMed]

26.

K. Sakatani, Y. Xie, W. Lichty, S. Li, and H. Zuo, “Language-Activated Cerebral Blood Oxygenation and Hemodynamic Changes of the Left Prefrontal Cortex in Poststroke Aphasic Patients : A Near-Infrared Spectroscopy Study,” Stroke 29(7), 1299–1304 (1998). [CrossRef] [PubMed]

27.

H. Kato, M. Izumiyama, H. Koizumi, A. Takahashi, and Y. Itoyama, “Near-Infrared Spectroscopic Topography as a Tool to Monitor Motor Reorganization After Hemiparetic Stroke: A Comparison With Functional MRI,” Stroke 33(8), 2032–2036 (2002). [CrossRef] [PubMed]

28.

I. Miyai, H. Yagura, M. Hatakenaka, I. Oda, I. Konishi, and K. Kubota, “Longitudinal Optical Imaging Study for Locomotor Recovery After Stroke,” Stroke 34(12), 2866–2870 (2003). [CrossRef] [PubMed]

29.

M. S. Damian and R. Schlosser, “Bilateral near infrared spectroscopy in space-occupying middle cerebral artery stroke,” Neurocritical Care 6(3), 165–173 (2007). [CrossRef] [PubMed]

30.

D. Hargroves, R. Tallis, V. Pomeroy, and A. Bhalla, “The influence of positioning upon cerebral oxygenation after acute stroke: a pilot study,” Age Ageing 37(5), 581–585 (2008). [CrossRef] [PubMed]

31.

D. A. Boas, L. E. Campbell, and A. G. Yodh, “Scattering and Imaging with Diffusing Temporal Field Correlations,” Phys Rev Lett 75(9), 1855–1858 (1995). [CrossRef] [PubMed]

32.

D. A. Boas and A. G. Yodh, “Spatially varying dynamical properties of turbid media probed with diffusing temporal light correlation,” J. Opt. Soc. Am. A 14(1), 192–215 (1997). [CrossRef]

33.

D. J. Pine, D. A. Weitz, P. M. Chaikin, and Herbolzheimer, “Diffusing-wave spectroscopy,” Phys. Rev. Lett. 60, 1134–1137 (1988). [CrossRef] [PubMed]

34.

G. Maret and P. E. Wolf, “Multiple light scattering from disordered media. The effect of brownian motion of scatterers,” Z. Phys. B 65, 409–413 (1987). [CrossRef]

35.

T. Durduran, “Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods,” Ph.D. Dissertation, University of Pennsylvania (2004).

36.

T. Durduran, G. Yu, M. G. Burnett, J. A. Detre, J. H. Greenberg, J. Wang, C. Zhou, and A. G. Yodh, “Diffuse Optical Measurements of Blood Flow, Blood Oxygenation and Metabolism in Human Brain during Sensorimotor Cortex Activation,” Opt Lett 29, 1766–1768 (2004). [CrossRef] [PubMed]

37.

J. Li, G. Dietsche, D. Iftime, S. E. Skipetrov, G. Maret, T. Elbert, B. Rockstroh, and T. Gisler, “Noninvasive detection of functional brain activity with near-infrared diffusing-wave spectroscopy,” J Biomed Opt 10(4), 044,002–1–044,002–12 (2005). [CrossRef]

38.

G. Yu, T. Durduran, C. Zhou, H. W. Wang, M. E. Putt, M. Saunders, C. M. Seghal, E. Glatstein, A. G. Yodh, and T. M. Busch, “Noninvasive Monitoring of Murine Tumor Blood Flow During and After Photodynamic Therapy Provides Early Assessment of Therapeutic Efficacy,” Clin. Cancer Res. 11, 3543–3552 (2005). [CrossRef] [PubMed]

39.

E. M. Buckley, M. N. Kim, T. Durduran, G. Yu, R. Choe, C. Zhou, S. Shultz, C. M. Sehgal, D. J. Licht, P. H. Arger, H. H. Hurt, N. M. Cook, and A. G. Yodh, “Monitoring Hemodynamic Changes in Preterm Infants Using Optical Spectroscopies and Doppler Ultrasound,” in OSA Biomedicals Topicals, p. CN279 (St Petersburg, FL, 2008).

40.

C. Menon, G. M. Polin, I. Prabakaran, A. Hs, C. Cheung, J. P. Culver, J. Pingpank, C. S. Sehgal, A. G. Yodh, D. G. Buerk, and D. L. Fraker, “An Integrated Approach to Measuring Tumor Oxygen Status using Human Melanoma Xenografts as a Model,” Cancer Res. 63, 7232–40 (2003). [PubMed]

41.

T. Durduran, M. N. Kim, E. M. Buckley, R. Choe, C. Zhou, G. Y. Yu, and A. G. Yodh, “Validation of diffuse correlation spectroscopy for measurement of cerebral blood flow across spatial scales and against multiple modalities,” in SPIE Photonics West (San Jose, CA, 2009).

42.

T. Durduran, C. Zhou, M. N. Kim, E. M. Buckley, G. Yu, R. Choe, S. M. Durning, S. Mason, L. M. Montenegro, S. C. Nicholson, R. A. Zimmerman, J. J. Wang, J. A. Detre, A. G. Yodh, and D. J. Licht, “Validation of Diffuse Correlation Spectroscopy for Non-Invasive, Continuous Monitoring of CBF in Neonates with Congenital Heart Defects,” in Annual Meeting of the American Neurological Association, p. Abstract 299 (American Neurological Association, Salt Lake City, Utah, 2008).

43.

T. Durduran, C. Zhou, G. Yu, R. Choe, D. Silvestre, J. J. Wang, S. Nicolson, L. Montenegro, J. A. Detre, A. G. Yodh, and D. Licht, “Preoperative measurement of CO2 reactivity and cerebral autoregulation in neonates with severe congenital heart defects,” in SPIE Photonics West (San Jose, CA, 2007).

44.

G. Yu, T. Floyd, T. Durduran, C. Zhou, J. J. Wang, J. A. Detre, and A. G. Yodh, “Validation of diffuse correlation spectroscopy for muscle blood flow with concurrent arterial-spin-labeling perfusion,” Opt Exp 15, 1064–75 (2007). [CrossRef]

45.

M. N. Kim, T. Durduran, S. Frangos, E. M. Buckley, C. Zhou, G. Yu, H. Moss, B. L. Edlow, E. Maloney-Wilensky, J. A. Detre, J. H. Greenberg, W. A. Kofke, A. G. Yodh, M. S. Grady, J. H. Woo, R. L. Wolf, and J. Levine, “Validation Of Diffuse Correlation Spectroscopy Against Xenon CTCBF In Humans After Traumatic Brain Injury or Subarachnoid Hemorrhage,” in Neurocritical Care Society Annual Meeting (Miami, FL, 2008).

46.

T. Durduran, M. N. Kim, E. M. Buckley, C. Zhou, G. Yu, R. Choe, J. H. Greenberg, J. A. Detre, and A. G. Yodh, “Diffuse Optical Monitoring of Cerebral Oxygen Metabolism at the Bed-Side in Cerebrovascular Disorders,” in OSA: Annual Meeting, Frontiers in Optics 2008 (Rochester, NY, 2008).

47.

C. Zhou, S. Eucker, T. Durduran, G. Yu, J. Ralston, S. Friess, R. Ichor, S. Margulies, and A. G. Yodh, “Diffuse Optical Monitoring of Hemodynamic Changes in Piglet Brain with Closed Head Injury,” Journal of Neurotrauma submitted (2009).

48.

J. P. Culver, T. Durduran, D. Furuya, C. Cheung, J. H. Greenberg, and A. G. Yodh, “Diffuse Optical Tomography of Cerebral Blood Flow, Oxygenation and Metabolism in Rat During Focal Ischemia,” J. Cereb. Blood Flow Metab. 23, 911–24 (2003). [CrossRef] [PubMed]

49.

C. Cheung, J. P. Culver, K. Takahashi, J. H. Greenberg, and A. G. Yodh, “In vivo cerebrovascular measurement combining diffuse near-infrared absorption and correlation spectroscopies,” Phys. Med. and Biol. 46(8), 2053–2065 (2001). [CrossRef]

50.

C. Zhou, G. Yu, D. Furuya, J. H. Greenberg, A. G. Yodh, and T. Durduran, “Diffuse Optical Correlation tomography of cerebral blood flow during cortical spreading depression in rat brain,” Opt. Exp 14, 1125–44 (2006). [CrossRef]

51.

T. Durduran, M. N. Kim, E. M. Buckley, B. L. Edlow, H. Moss, C. Zhou, G. Yu, R. Choe, S. K. Frangos, E. Wilensky-Mahoney, A. Kofke, J. M. Levine, R. L. Wolf, J. Woo, S. E. Kasner, B. L. Cucchiara, M. E. Putt, A. G. Yodh, J. H. Greenberg, and J. A. Detre, “Bedside Monitoring of Cerebral Hemodynamics for Stroke and Neurocritical Care Using Novel Diffuse Optical Probes,” in Annual Meeting of the American Neurological Association, p. Abstract 298 (American Neurological Association, Salt Lake City, Utah, 2008).

52.

T. Durduran, C. Zhou, B. L. Edlow, G. Yu, R. Choe, B. L. Cucchiara, M. Putt, Q. Shah, S. E. Kasner, A. G. Yodh, J. H. Greenberg, and J. A. Detre, “CBF During Changes in Head of Bed Position in Acute, Ischemic Stroke Monitored at the bed-side: hemispheric effect of infarct,” in BRAIN 07, International Society of Cerebral Blood Flow and Metabolism (Osaka, Japan, 2007).

53.

T. Durduran, C. Zhou, G. Yu, B. Edlow, R. Choe, Q. Shah, S. E. Kasner, B. L. Cucchiara, A. G. Yodh, J. H. Greenberg, and J. A. Detre, “Bed-side Monitoring of Cerebral Blood Flow (CBF) in Acute Stroke Patients During Changes in Head of Bed Position,” in International Stroke Conference, vol. P37 (American Heart Association, 2007).

54.

M. N. Kim, T. Durduran, S. Frangos, E. M. Buckley, C. Zhou, G. Yu, B. L. Edlow, E. Mahoney-Wilensky, S. M. Grady, J. Levine, J. A. Detre, J. H. Greenberg, and A. G. Yodh, “Diffuse Optical Measurements of Cerebral Blood Flow and Oxygenation in Patients after Traumatic Brain Injury or Subarachnoid Hemhorrage,” in OSA Biomedicals Topicals, p. CN237 (St Petersburg, FL, 2008).

55.

G. Yu, T. Durduran, G. Lech, C. Zhou, B. Chance, E. R. Mohler, and A. G. Yodh, “Time-dependent Blood Flow and Oxygenation in Human Skeletal Muscle Measured with Noninvasive Near-infrared Diffuse Optical Spectroscopies,” J Biomed Opt 10(3), 024,027–1–12 (2005). [CrossRef]

56.

G. Yu, T. Durduran, C. Zhou, T. C. Zhu, J. C. Finlay, T. M. Busch, S. B. Malkowicz, S. M. Hahn, and A. G. Yodh, “Real-time In situ Monitoring of Human Prostate Photodynamic Therapy with Diffuse Light,” Photochem Photobiol 82, 1279–84 (2006). [CrossRef] [PubMed]

57.

U. Sunar, H. Quon, T. Durduran, J. Zhang, J. Du, C. Zhou, G. Yu, R. Choe, A. Kilger, R. Lustig, L. Loevner, S. Nioka, B. Chance, and A. G. Yodh, “Non-invasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study,” J Biomed Opt 11, 064,021 (2006). [CrossRef]

58.

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J Biomed Opt 12(5), 051,903 (2007). [CrossRef]

59.

U. Sunar, S. Makonnen, C. Zhou, T. Durduran, G. Yu, H. W. Wang, W. M. Lee, and A. G. Yodh, “Hemodynamic responses to antivascular therapy and ionizing radiation assessed by diffuse optical spectroscopies,” Opt. Express 15(23), 15,507–15,516 (2007). [CrossRef]

60.

T. Durduran, R. Choe, G. Yu, C. Zhou, J. C. Tchou, B. J. Czerniecki, and A. G. Yodh, “Diffuse Optical Measurement of Blood flow in Breast Tumors,” Opt Lett 30, 2915–17 (2005). [CrossRef] [PubMed]

61.

H. P. Adams, B. H. Bendixen, L. J. Kappelle, J. Biller, B. B. Love, D. L. Gordon, and E. E. Marsh, “Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment,” Stroke 24(1), 35–41 (1993). [CrossRef] [PubMed]

62.

D. T. Delpy, M. Cope, P. van der Zee, S. Arridge, S. Wray, and J. Wyatt, “Estimation of optical pathlength through tissue from direct time of flight measurement,” Phys Med Biol 33, 1433–1442 (1988). [CrossRef] [PubMed]

63.

M. Cope and D. T. Delpy, “System for long-term measurement of cerebral blood flow and tissue oxygenation on newborn infants by infra-red transillumination.” Med Biol Eng Comput 26, 289–294 (1988). [CrossRef] [PubMed]

64.

P. van der Zee, M. Cope, S. R. Arridge, M. Essenpreis, L. A. Potter, A. D. Edwards, J. S. Wyatt, D. C. McCormick, S. C. Toth, E. O. R. Reynolds, and D. T. Delpy, “Experimentally measured optical pathlengths for the adult’s head, calf and forearm and the head of the newborn infant asa function of interoptode spacing,” Adv. Exp. Med. Biol. 316, 143–153 (1992). [CrossRef] [PubMed]

65.

A. Duncan, J. H. Meek, M. Clemence, C. E. Elwell, L. Tyszczuk, M. Cope, and D. T. Delpy, “Optical pathlength measurements on adult head, calf and forearm and the head of the newborn infant using phase resolved optical spectroscopy,” Phys. Med. Biol. 40(2), 295–304. (1995). [CrossRef] [PubMed]

66.

M. Kohl, C. Nolte, H. R. Heekeren, S. Horst, U. Scholz, H. Obrig, and A. Villringer, “Determination of the wavelength dependence of the differential pathlength factor from near-infrared pulse signals,” Phys Med Biol 43(6), 1771–82 (1998). [CrossRef] [PubMed]

67.

S. R. Arridge, M. Cope, and D. T. Delpy, “The theoretical basis for the determination of optical pathlengths in tissue: temporal and frequency analysis,” Phys Med Biol 37(7), 1531–60 (1992). [CrossRef] [PubMed]

68.

Compiled by Scott Prahl, Online: http://omlc.ogi.edu/spectra/hemoglobin/summary.html.

69.

G. Strangman, M. A. Franceschini, and D. A. Boas, “Factors affecting the accuracy of near-infrared spectroscopy concentration calculations for focal changes in oxygenation parameters,” NeuroImage 18, 865–79 (2003). [CrossRef] [PubMed]

70.

D. A. Boas, T. Gaudette, G. Strangman, X. Cheng, J. J. A. Marota, and J. B. Mandeville, “The Accuracy of Near Infrared Spectroscopy and Imaging during Focal Changes in Cerebral Hemodynamics,” NeuroImage 13, 76–90 (2001). [CrossRef] [PubMed]

71.

E. Okada and D. T. Delpy, “Near-Infrared light propagation in an adult head model. II. Effect of superficial tissue thickness on the sensitivity of the near-infrared spectroscopy signal,” Appl. Opt. 42, 2915–21 (2003). [CrossRef] [PubMed]

72.

J. Steinbrink, H. Wabnitz, H. Obrig, A. Villringer, and H. Rinneberg, “Determining changes in NIR absorption using a layered model of the human head,” Phys Med Biol 46(3), 879–96. (2001). [CrossRef] [PubMed]

73.

A. Einstein, “On the motion of small particles suspended in liquids at rest required by the molecular-kinetic theory of heat,” Annalen der Physik 17, 549–60 (1905). [CrossRef]

74.

J. C. Pinheiro and D. M. Bates, Mixed-effects models in S and S-Plus (Springer, New York, 2000). [CrossRef]

75.

H. Akaike, “A new look at the statistical model identification,” Automatic Control, IEEE Transactions on 19(6), 716–723 (1974). [CrossRef]

76.

A. Chieregato, A. Tanfani, C. Compagnone, R. Pascarella, L. Targa, and E. Fainardi, “Cerebral blood flow in traumatic contusions is predominantly reduced after an induced acute elevation of cerebral perfusion pressure,” Neurosurgery 60(1), 115–123 (2007). [CrossRef] [PubMed]

77.

P. Langhorne, D. J. Stott, L. Robertson, J. MacDonald, L. Jones, C. McAlpine, F. Dick, G. S. Taylor, and G. Murray, “Medical complications after stroke: a multicenter study,” Stroke 31(6), 1223–1229 (2000). [CrossRef] [PubMed]

78.

R. Fernandez-Crehuet, C. Diaz-Molina, J. de Irala, D. Martinez-Concha, I. Salcedo-Leal, and J. Masa-Calles, “Nosocomial infection in an intensive-care unit: identification of risk factors.” Infect Control Hosp Epidemiol 18(12), 825–30 (1997). [CrossRef]

79.

S. I. Kamran, D. Downey, and R. L. Ruff, “Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients,” Neurology 50(6), 1683–1688 (1998). [PubMed]

80.

J. Kelly, A. Rudd, R. Lewis, and B. J. Hunt, “Venous thromboembolism after acute stroke,” Stroke 32(1), 262–267 (2001). [CrossRef] [PubMed]

81.

C. Dohmen, B. Bosche, R. Graf, T. Reithmeier, R. I. Ernestus, G. Brinker, J. Sobesky, and W. D. Heiss, “Identification and clinical impact of impaired cerebrovascular autoregulation in patients with malignant middle cerebral artery infarction,” Stroke 38(1), 56–61 (2007). [CrossRef]

82.

A. W. Wojner-Alexander, Z. Garami, O. Y. Chernyshev, and A. V. Alexandrov, “Heads down: flat positioning improves blood flow velocity in acute ischemic stroke,” Neurology 64(8), 1354–1357 (2005). [CrossRef] [PubMed]

83.

W. K. Paula, “Heads down: flat positioning improves blood flow velocity in acute ischemic stroke,” Neurology 65(9), 1514–1514 (2005). [PubMed]

84.

L. A. Lipsitz, S. Mukai, J. Hamner, M. Gagnon, and V. Babikian, “Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension,” Stroke 31(8), 1897–1903 (2000). [CrossRef] [PubMed]

85.

T. Asil, U. Utku, K. Balci, and I. Uzunca, “Changing cerebral blood flow velocity by transcranial Doppler during head up tilt in patients with diabetes mellitus,” Clin Neurol Neurosurg 109(1), 1–6 (2007). [CrossRef]

86.

J. Adams, Harold P, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, P. D. Lyden, L. B. Morgenstern, A. I. Qureshi, R. H. Rosenwasser, P. A. Scott, and E. F. Wijdicks, “Guidelines for the Early Management of Adults With Ischemic Stroke,”.

OCIS Codes
(170.3340) Medical optics and biotechnology : Laser Doppler velocimetry
(170.3880) Medical optics and biotechnology : Medical and biological imaging
(170.5280) Medical optics and biotechnology : Photon migration
(170.6480) Medical optics and biotechnology : Spectroscopy, speckle
(280.1415) Remote sensing and sensors : Biological sensing and sensors

ToC Category:
Medical Optics and Biotechnology

History
Original Manuscript: November 24, 2008
Revised Manuscript: January 22, 2009
Manuscript Accepted: January 25, 2009
Published: February 27, 2009

Virtual Issues
Vol. 4, Iss. 5 Virtual Journal for Biomedical Optics

Citation
Turgut Durduran, Chao Zhou, Brian L. Edlow, Guoqiang Yu, Regine Choe, Meeri N. Kim, Brett L. Cucchiara, Mary E. Putt, Qaisar Shah, Scott E. Kasner, Joel H. Greenberg, Arjun G. Yodh, and John A. Detre, "Transcranial optical monitoring of cerebrovascular hemodynamics in acute stroke patients," Opt. Express 17, 3884-3902 (2009)
http://www.opticsinfobase.org/vjbo/abstract.cfm?URI=oe-17-5-3884


Sort:  Author  |  Year  |  Journal  |  Reset  

References

  1. A. D. Lopez, C. D. Mathers, M. Ezzati, D. T. Jamison, and C. J. L. Murray, "Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data," The Lancet 367(9524), 1747-1757 (2006). [CrossRef]
  2. European Stroke Organization, "Recommendations for Stroke Management," http://www.eso-stroke.org/recommendations.php?cid=9&sid=1(Last Accessed: January 22, 2009).
  3. C. Benesch and R. Holloway, "Economic Impact of Stroke and Implications for Interventions." CNS Drugs 9, 19 (1998). [CrossRef]
  4. L. B. Goldstein, "Should antihypertensive therapies be given to patients with acute ischemic stroke?" Drug Saf 22, 13-18 (2000). [CrossRef] [PubMed]
  5. S. L. Dawson, R. B. Panerai, and J. F. Potter, "Serial changes in static and dynamic cerebral autoregulation after acute ischaemic stroke," Cerebrovasc Dis 16, 69-75 (2003). [CrossRef] [PubMed]
  6. K. A. Hossmann, "Viability thresholds and the penumbra of focal ischemia," Ann Neurol 36, 557-565 (1994). [CrossRef] [PubMed]
  7. J. Astrup, B. K. Siesjo, and L. Symon, "Thresholds in cerebral ischemia - the ischemic penumbra," Stroke 12 723-725 (1981). [CrossRef] [PubMed]
  8. M. Wintermark, M. Sesay, E. Barbier, K. Borbely, W. P. Dillon, J. D. Eastwood, T. C. Glenn, C. B. Grandin, S. Pedraza, J. F. Soustiel, T. Nariai, G. Zaharchuk, J. M. Caille, V. Dousset, and H. Yonas, "Comparative overview of brain perfusion imaging techniques," Stroke 36, 83-99 (2005). [CrossRef]
  9. J. C. Baron, "Mapping the ischaemic penumbra with PET: a new approach," Brain 124(Pt 1), 2-4 (2001). [CrossRef] [PubMed]
  10. M. H. Mahagne, O. David, J. Darcourt, O. Migneco, A. Dunac, M. Chatel, and J. C. Baron, "Voxel-based mapping of cortical ischemic damage using Tc 99m L,L-ethyl cysteinate dimmer SPECT in acute stroke," J Neuroimaging 14, 23-32 (2004). [PubMed]
  11. R. E. Latchaw, "Cerebral perfusion imaging in acute stroke," J Vasc Interv Radiol 15(1 Pt 2), 29-46 (2004).
  12. J. A. Chalela, D. C. Alsop, J. B. Gonzalez-Atavales, J. A. Maldjian, S. E. Kasner, and J. A. Detre, "Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling," Stroke 31, 680-687 (2000). [CrossRef] [PubMed]
  13. C. C. Bishop, S. Powell, D. Rutt, and N. L. Browse, "Transcranial Doppler measurement of middle cerebral artery blood flow velocity: a validation study," Stroke 17, 913-915 (1986). [CrossRef] [PubMed]
  14. R. R. Pindzola, J. R. Balzer, E. M. Nemoto, S. Goldstein, and H. Yonas, "Cerebrovascular reserve in patients with carotid occlusive disease assessed by stable xenon-enhanced ct cerebral blood flow and transcranial Doppler," Stroke 32, 1811-1817 (2001). [CrossRef] [PubMed]
  15. A. V. Alexandrov, A. M. Demchuk, T. H. Wein, and J. C. Grotta, "Yield of transcranial Doppler in acute cerebral ischemia," Stroke 30, 1604-1609 (1999). [CrossRef] [PubMed]
  16. S. Schwarz, D. Georgiadis, A. Aschoff, and S. Schwab, "Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke," Stroke 33, 497-501 (2002). [CrossRef] [PubMed]
  17. A. Villringer and B. Chance, "Non-invasive optical spectroscopy and imaging of human brain function," Trends Neurosci. 20, 435-442 (1997). [CrossRef] [PubMed]
  18. E. M. C. Hillman, "Optical brain imaging in vivo: techniques and applications from animal to man," Journal of Biomedical Optics 12(5) (2007). [CrossRef] [PubMed]
  19. W. M. Kuebler, "How NIR is the future in blood flow monitoring?" J Appl Physiol 104, 905-906 (2008). [CrossRef] [PubMed]
  20. R. Carandang and D. W. Krieger, "Near infrared spectroscopy: finding utility in malignant hemi- spheric stroke," Neurocritical Care 6, 161-164 (2007). [CrossRef] [PubMed]
  21. C. Terborg, S. Bramer, S. Harscher, M. Simon, and O. W. Witte, "Bedside assessment of cerebral perfusion reductions in patients with acute ischaemic stroke by near-infrared spectroscopy and indocyanine green," J. Neurol. Neurosurg. Psychiatry 75, 38-42 (2004). [PubMed]
  22. A. Liebert, H. Wabnitz, J. Steinbrink, M. Moller, R. Macdonald, H. Rinneberg, A. Villringer, and H. Obrig, "Bed-side assessment of cerebral perfusion in stroke patients based on optical monitoring of a dye bolus by time-resolved diffuse reflectance," Neuroimage 24, 426-35 (2005). [CrossRef] [PubMed]
  23. E. Keller, G. Wietasch, P. Ringleb, M. Scholz, S. Schwarz, R. Stingele, S. Schwab, D. Hanley, and W. Hacke, "Bedside monitoring of cerebral blood flow in patients with acute hemispheric stroke," Crit Care Med 28, 511-516 (2000). [CrossRef] [PubMed]
  24. F. Vernieri, N. Rosato, F. Pauri, F. Tibuzzi, F. Passarelli, and P. M. Rossini, "Near Infrared Spectroscopy and Transcranial Doppler in Monohemispheric Stroke," Eur. Neurol. 41, 159-162 (1999). [CrossRef] [PubMed]
  25. P. Bonoczk, G. Panczel, and Z. Nagy, "Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study," European Journal of Ultrasound 15(1-2), 85-91 (2002). [CrossRef] [PubMed]
  26. K. Sakatani, Y. Xie, W. Lichty, S. Li, and H. Zuo, "Language-Activated Cerebral Blood Oxygena- tion and Hemodynamic Changes of the Left Prefrontal Cortex in Poststroke Aphasic Patients : A Near-Infrared Spectroscopy Study," Stroke 29(7), 1299-1304 (1998). [CrossRef] [PubMed]
  27. H. Kato, M. Izumiyama, H. Koizumi, A. Takahashi, and Y. Itoyama, "Near-Infrared Spectroscopic Topography as a Tool to Monitor Motor Reorganization After Hemiparetic Stroke: A Comparison With Functional MRI," Stroke 33, 2032-2036 (2002). [CrossRef] [PubMed]
  28. I. Miyai, H. Yagura, M. Hatakenaka, I. Oda, I. Konishi, and K. Kubota, "Longitudinal Optical Imaging Study for Locomotor Recovery After Stroke," Stroke 34, 2866-2870 (2003). [CrossRef] [PubMed]
  29. M. S. Damian and R. Schlosser, "Bilateral near infrared spectroscopy in space-occupying middle cerebral artery stroke," Neurocritical Care 6, 165-173 (2007). [CrossRef] [PubMed]
  30. D. Hargroves, R. Tallis, V. Pomeroy, and A. Bhalla, "The influence of positioning upon cerebral oxygenation after acute stroke: a pilot study," Age Ageing 37, 581-585 (2008). [CrossRef] [PubMed]
  31. D. A. Boas, L. E. Campbell, and A. G. Yodh, "Scattering and Imaging with Diffusing Temporal Field Correlations," Phys Rev Lett 75, 1855-1858 (1995). [CrossRef] [PubMed]
  32. D. A. Boas and A. G. Yodh, "Spatially varying dynamical properties of turbid media probed with diffusing temporal light correlation," J. Opt. Soc. Am. A 14, 192-215 (1997). [CrossRef]
  33. D. J. Pine, D. A. Weitz, P. M. Chaikin, and Herbolzheimer, "Diffusing-wave spectroscopy," Phys. Rev. Lett. 60, 1134-1137 (1988). [CrossRef] [PubMed]
  34. G. Maret and P. E. Wolf, "Multiple light scattering from disordered media. The effect of Brownian motion of scatterers," Z. Phys. B 65, 409-413 (1987). [CrossRef]
  35. T. Durduran, "Non-Invasive Measurements of Tissue Hemodynamics with Hybrid Diffuse Optical Methods," Ph.D. Dissertation, University of Pennsylvania (2004).
  36. T. Durduran, G. Yu, M. G. Burnett, J. A. Detre, J. H. Greenberg, J. Wang, C. Zhou, and A. G. Yodh, "Diffuse Optical Measurements of Blood Flow, Blood Oxygenation and Metabolism in Human Brain during Sensorimotor Cortex Activation," Opt. Lett. 29, 1766-1768 (2004). [CrossRef] [PubMed]
  37. J. Li, G. Dietsche, D. Iftime, S. E. Skipetrov, G. Maret, T. Elbert, B. Rockstroh, and T. Gisler, "Noninvasive detection of functional brain activity with near-infrared diffusing-wave spectroscopy," J. Biomed. Opt. 10, 044,002-1-044,002-12 (2005). [CrossRef]
  38. G. Yu, T. Durduran, C. Zhou, H. W. Wang, M. E. Putt, M. Saunders, C. M. Seghal, E. Glatstein, A. G. Yodh, and T. M. Busch, "Noninvasive Monitoring of Murine Tumor Blood Flow During and After Photodynamic Therapy Provides Early Assessment of Therapeutic Efficacy," Clin. Cancer Res. 11, 3543-3552 (2005). [CrossRef] [PubMed]
  39. E. M. Buckley, M. N. Kim, T. Durduran, G. Yu, R. Choe, C. Zhou, S. Shultz, C. M. Sehgal, D. J. Licht, P. H. Arger, H. H. Hurt, N. M. Cook, and A. G. Yodh, "Monitoring Hemodynamic Changes in Preterm Infants Using Optical Spectroscopies and Doppler Ultrasound," in OSA Biomedicals Topicals, p. CN279 (St Petersburg, FL, 2008).
  40. C. Menon, G. M. Polin, I. Prabakaran, A. Hs, C. Cheung, J. P. Culver, J.. Pingpank, C. S. Sehgal, A. G. Yodh, D. G. Buerk, and D. L. Fraker, "An Integrated Approach to Measuring Tumor Oxygen Status using Human Melanoma Xenografts as a Model," Cancer Res. 63, 7232-40 (2003). [PubMed]
  41. T. Durduran, M. N. Kim, E. M. Buckley, R. Choe, C. Zhou, G. Y. Yu, and A. G. Yodh, "Validation of diffuse correlation spectroscopy for measurement of cerebral blood flow across spatial scales and against multiple modalities," in SPIE Photonics West (San Jose, CA, 2009).
  42. T. Durduran, C. Zhou, M. N. Kim, E. M. Buckley, G. Yu, R. Choe, S. M. Durning, S. Mason, L. M. Montenegro, S. C. Nicholson, R. A. Zimmerman, J. J. Wang, J. A. Detre, A. G. Yodh, and D. J. Licht, "Validation of Diffuse Correlation Spectroscopy for Non-Invasive, Continuous Monitoring of CBF in Neonates with Congenital Heart Defects," in Annual Meeting of the American Neurological Association, p. Abstract 299 (American Neurological Association, Salt Lake City, Utah, 2008).
  43. T. Durduran, C. Zhou, G. Yu, R. Choe, D. Silvestre, J. J. Wang, S. Nicolson, L. Montenegro, J. A. Detre, A. G. Yodh, and D. Licht, "Preoperative measurement of CO2 reactivity and cerebral autoregulation in neonates with severe congenital heart defects," in SPIE Photonics West (San Jose, CA, 2007).
  44. G. Yu, T. Floyd, T. Durduran, C. Zhou, J. J. Wang, J. A. Detre, and A. G. Yodh, "Validation of diffuse correlation spectroscopy for muscle blood flow with concurrent arterial-spin-labeling perfusion," Opt Exp 15, 1064-75 (2007). [CrossRef]
  45. M. N. Kim, T. Durduran, S. Frangos, E. M. Buckley, C. Zhou, G. Yu, H. Moss, B. L. Edlow, E. Maloney-Wilensky, J. A. Detre, J. H. Greenberg, W. A. Kofke, A. G. Yodh, M. S. Grady, J. H. Woo, R. L. Wolf, and J. Levine, "Validation Of Diffuse Correlation Spectroscopy Against Xenon CTCBF In Humans After Traumatic Brain Injury or Subarachnoid Hemorrhage," in Neurocritical Care Society Annual Meeting (Miami, FL, 2008).
  46. T. Durduran, M. N. Kim, E. M. Buckley, C. Zhou, G. Yu, R. Choe, J. H. Greenberg, J. A. Detre, and A. G. Yodh, "Diffuse Optical Monitoring of Cerebral Oxygen Metabolism at the Bed-Side in Cerebrovascular Disorders," in OSA: Annual Meeting, Frontiers in Optics 2008 (Rochester, NY, 2008).
  47. C. Zhou, S. Eucker, T. Durduran, G. Yu, J. Ralston, S. Friess, R. Ichor, S. Margulies, and A. G. Yodh, "Diffuse Optical Monitoring of Hemodynamic Changes in Piglet Brain with Closed Head Injury," J. Neurotrauma submitted (2009).
  48. J. P. Culver, T. Durduran, D. Furuya, C. Cheung, J. H. Greenberg, and A. G. Yodh, "Diffuse Optical Tomography of Cerebral Blood Flow, Oxygenation and Metabolism in Rat During Focal Ischemia," J. Cereb. Blood Flow Metab. 23, 911-24 (2003). [CrossRef] [PubMed]
  49. C. Cheung, J. P. Culver, K. Takahashi, J. H. Greenberg, and A. G. Yodh, "In vivo cerebrovascular measurement combining diffuse near-infrared absorption and correlation spectroscopies," Phys. Med. and Biol. 46, 2053-2065 (2001). [CrossRef]
  50. C. Zhou, G. Yu, D. Furuya, J. H. Greenberg, A. G. Yodh, and T. Durduran, "Diffuse Optical Correlation tomography of cerebral blood flow during cortical spreading depression in rat brain," Opt. Express 14, 1125-44 (2006). [CrossRef]
  51. T. Durduran, M. N. Kim, E. M. Buckley, B. L. Edlow, H. Moss, C. Zhou, G. Yu, R. Choe, S. K. Frangos, E. Wilensky-Mahoney, A. Kofke, J. M. Levine, R. L. Wolf, J. Woo, S. E. Kasner, B. L. Cucchiara, M. E. Putt, A. G. Yodh, J. H. Greenberg, and J. A. Detre, "Bedside Monitoring of Cerebral Hemodynamics for Stroke and Neurocritical Care using Novel Diffuse Optical Probes," in Annual Meeting of the American Neurological Association, p. Abstract 298 (American Neuro- logical Association, Salt Lake City, Utah, 2008).
  52. T. Durduran, C. Zhou, B. L. Edlow, G. Yu, R. Choe, B. L. Cucchiara, M. Putt, Q. Shah, S. E. Kasner, A. G. Yodh, J. H. Greenberg, and J. A. Detre, "CBF During Changes in Head of Bed Position in Acute, Ischemic Stroke Monitored at the bed-side: hemispheric effect of infarct," in BRAIN 07, International Society of Cerebral Blood Flow and Metabolism (Osaka, Japan, 2007).
  53. T. Durduran, C. Zhou, G. Yu, B. Edlow, R. Choe, Q. Shah, S. E. Kasner, B. L. Cucchiara, A. G. Yodh, J. H. Greenberg, and J. A. Detre, "Bed-side Monitoring of Cerebral Blood Flow (CBF) in Acute Stroke Patients During Changes in Head of Bed Position," in International Stroke Conference, vol. P37 (American Heart Association, 2007).
  54. M. N. Kim, T. Durduran, S. Frangos, E. M. Buckley, C. Zhou, G. Yu, B. L. Edlow, E. Mahoney- Wilensky, S. M. Grady, J. Levine, J. A. Detre, J. H. Greenberg, and A. G. Yodh, "Diffuse Optical Measurements of Cerebral Blood Flow and Oxygenation in Patients after Traumatic Brain Injury or Subarachnoid Hemhorrage," in OSA Biomedicals Topicals, p. CN237 (St Petersburg, FL, 2008).
  55. G. Yu, T. Durduran, G. Lech, C. Zhou, B. Chance, E. R. Mohler, and A. G. Yodh, "Time- dependent Blood Flow and Oxygenation in Human Skeletal Muscle Measured with Noninvasive Near-infrared Diffuse Optical Spectroscopies," J Biomed Opt 10, 024,027-1-12 (2005). [CrossRef]
  56. G. Yu, T. Durduran, C. Zhou, T. C. Zhu, J. C. Finlay, T. M. Busch, S. B. Malkowicz, S. M. Hahn, and A. G. Yodh, "Real-time In situ Monitoring of Human Prostate Photodynamic Therapy with Diffuse Light," Photochem Photobiol 82, 1279-84 (2006). [CrossRef] [PubMed]
  57. U. Sunar, H. Quon, T. Durduran, J. Zhang, J. Du, C. Zhou, G. Yu, R. Choe, A. Kilger, R. Lustig, L. Loevner, S. Nioka, B. Chance, and A. G. Yodh, "Non-invasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study," J Biomed Opt 11, 064,021 (2006). [CrossRef]
  58. C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, "Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy," J Biomed Opt 12, 051,903 (2007). [CrossRef]
  59. U. Sunar, S. Makonnen, C. Zhou, T. Durduran, G. Yu, H. W. Wang, W. M. Lee, and A. G. Yodh, "Hemodynamic responses to antivascular therapy and ionizing radiation assessed by diffuse optical spectroscopies," Opt. Express 15, 15,507-15,516 (2007). [CrossRef]
  60. T. Durduran, R. Choe, G. Yu, C. Zhou, J. C. Tchou, B. J. Czerniecki, and A. G. Yodh, "Diffuse Optical Measurement of Blood flow in Breast Tumors," Opt Lett 30, 2915-17 (2005). [CrossRef] [PubMed]
  61. H. P. Adams, B. H. Bendixen, L. J. Kappelle, J. Biller, B. B. Love, D. L. Gordon, and E. E. Marsh, "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment," Stroke 24, 35-41 (1993). [CrossRef] [PubMed]
  62. D. T. Delpy, M. Cope, P. van der Zee, S. Arridge, S. Wray, and J. Wyatt, "Estimation of optical pathlength through tissue from direct time of flight measurement," Phys. Med. Biol. 33, 1433-1442 (1988). [CrossRef] [PubMed]
  63. M. Cope and D. T. Delpy, "System for long-term measurement of cerebral blood flow and tissue oxygenation on newborn infants by infra-red transillumination," Med. Biol. Eng. Comput. 26, 289- 294 (1988). [CrossRef] [PubMed]
  64. P. van der Zee, M. Cope, S. R. Arridge, M. Essenpreis, L. A. Potter, A. D. Edwards, J. S. Wyatt, D. C. McCormick, S. C. Toth, E. O. R. Reynolds, and D. T. Delpy, "Experimentally measured optical pathlengths for the adult’s head, calf and forearm and the head of the newborn infant asa function of interoptode spacing," Adv. Exp. Med. Biol. 316, 143-153 (1992). [CrossRef] [PubMed]
  65. A. Duncan, J. H. Meek, M. Clemence, C. E. Elwell, L. Tyszczuk, M. Cope, and D. T. Delpy, "Optical pathlength measurements on adult head, calf and forearm and the head of the newborn infant using phase resolved optical spectroscopy," Phys. Med. Biol. 40, 295-304. (1995). [CrossRef] [PubMed]
  66. M. Kohl, C. Nolte, H. R. Heekeren, S. Horst, U. Scholz, H. Obrig, and A. Villringer, "Determination of the wavelength dependence of the differential pathlength factor from near-infrared pulse signals," Phys Med Biol 43(6), 1771-1782 (1998). [CrossRef] [PubMed]
  67. S. R. Arridge, M. Cope, and D. T. Delpy, "The theoretical basis for the determination of optical pathlengths in tissue: temporal and frequency analysis," Phys. Med. Biol. 37, 1531-60 (1992). [CrossRef] [PubMed]
  68. Compiled by Scott Prahl, Online: http://omlc.ogi.edu/spectra/hemoglobin/summary.html.
  69. G. Strangman, M. A. Franceschini, and D. A. Boas, "Factors affecting the accuracy of near- infrared spectroscopy concentration calculations for focal changes in oxygenation parameters," NeuroImage 18, 865-79 (2003). [CrossRef] [PubMed]
  70. D. A. Boas, T. Gaudette, G. Strangman, X. Cheng, J. J. A. Marota, and J. B. Mandeville, "The Accuracy of Near Infrared Spectroscopy and Imaging during Focal Changes in Cerebral Hemodynamics," NeuroImage 13, 76-90 (2001). [CrossRef] [PubMed]
  71. E. Okada and D. T. Delpy, "Near-Infrared light propagation in an adult head model. II. Effect of superficial tissue thickness on the sensitivity of the near-infrared spectroscopy signal," Appl. Opt. 42, 2915-21 (2003). [CrossRef] [PubMed]
  72. J. Steinbrink, H. Wabnitz, H. Obrig, A. Villringer, and H. Rinneberg, "Determining changes in NIR absorption using a layered model of the human head," Phys Med Biol 46, 879-96. (2001). [CrossRef] [PubMed]
  73. A. Einstein, "On the motion of small particles suspended in liquids at rest required by the molecular-kinetic theory of heat," Annalen der Physik 17, 549-60 (1905). [CrossRef]
  74. J. C. Pinheiro and D. M. Bates, Mixed-effects models in S and S-Plus (Springer, New York, 2000). [CrossRef]
  75. H. Akaike, "A new look at the statistical model identification," Automatic Control, IEEE Trans- actions on 19(6), 716-723 (1974). [CrossRef]
  76. A. Chieregato, A. Tanfani, C. Compagnone, R. Pascarella, L. Targa, and E. Fainardi, "Cerebral blood flow in traumatic contusions is predominantly reduced after an induced acute elevation of cerebral perfusion pressure," Neurosurgery 60, 115-123 (2007). [CrossRef] [PubMed]
  77. P. Langhorne, D. J. Stott, L. Robertson, J. MacDonald, L. Jones, C. McAlpine, F. Dick, G. S. Taylor, and G. Murray, "Medical complications after stroke: a multicenter study," Stroke 31, 1223-1229 (2000). [CrossRef] [PubMed]
  78. R. Fernandez-Crehuet, C. Diaz-Molina, J. de Irala, D. Martinez-Concha, I. Salcedo-Leal, and J. Masa-Calles, "Nosocomial infection in an intensive-care unit: identification of risk factors." Infect Control Hosp Epidemiol 18, 825-830 (1997). [CrossRef]
  79. S. I. Kamran, D. Downey, and R. L. Ruff, "Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients," Neurology 50, 1683-1688 (1998). [PubMed]
  80. J. Kelly, A. Rudd, R. Lewis, and B. J. Hunt, "Venous thromboembolism after acute stroke," Stroke 32, 262-267 (2001). [CrossRef] [PubMed]
  81. C. Dohmen, B. Bosche, R. Graf, T. Reithmeier, R. I. Ernestus, G. Brinker, J. Sobesky, and W. D. Heiss, "Identification and clinical impact of impaired cerebrovascular autoregulation in patients with malignant middle cerebral artery infarction," Stroke 38, 56-61 (2007). [CrossRef]
  82. A. W. Wojner-Alexander, Z. Garami, O. Y. Chernyshev, and A. V. Alexandrov, "Heads down: flat positioning improves blood flow velocity in acute ischemic stroke," Neurology 64, 1354-1357 (2005). [CrossRef] [PubMed]
  83. W. K. Paula, "Heads down: flat positioning improves blood flow velocity in acute ischemic stroke," Neurology 65, 1514-1514 (2005). [PubMed]
  84. L. A. Lipsitz, S. Mukai, J. Hamner, M. Gagnon, and V. Babikian, "Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension," Stroke 31, 1897-1903 (2000). [CrossRef] [PubMed]
  85. T. Asil, U. Utku, K. Balci, and I. Uzunca, "Changing cerebral blood flow velocity by transcranial Doppler during head up tilt in patients with diabetes mellitus," Clin Neurol Neurosurg 109, 1-6 (2007). [CrossRef]
  86. J. Adams, HaroldP , G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, P. D. Lyden, L. B. Morgenstern, A. I. Qureshi, R. H. Rosenwasser, P. A. Scott, and E. F. Wijdicks, "Guidelines for the Early Management of Adults With Ischemic Stroke,".

Cited By

Alert me when this paper is cited

OSA is able to provide readers links to articles that cite this paper by participating in CrossRef's Cited-By Linking service. CrossRef includes content from more than 3000 publishers and societies. In addition to listing OSA journal articles that cite this paper, citing articles from other participating publishers will also be listed.

Figures

Fig. 1. Fig. 2. Fig. 3.
 
Fig. 4.
 

« Previous Article  |  Next Article »

OSA is a member of CrossRef.

CrossCheck Deposited